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This study identified the molecular defects behind three lethal fetal 
syndromes. Lethal Congenital Contracture Syndrome 1 (LCCS1, MIM 
253310) and Lethal Arthrogryposis with Anterior Horn Cell Disease (LAAHD, 
MIM 611890) are fetal motor neuron diseases. They affect the nerve cells 
that control voluntary muscle movement, and eventually result in severe 
atrophy of spinal cord motor neurons and fetal immobility. Both LCCS1 
and LAAHD are caused by mutations in the GLE1 gene, which encodes for 
a multifunctional protein involved in posttranscriptional mRNA processing. 
The third lethal fetal syndrome, Cocoon syndrome (MIM 613630), is 
described in this study for the first time. Its hallmarks are the encasement 
of the limbs under the skin, and severe craniofacial abnormalities, including 
the lack of skull bones. Cocoon syndrome is caused by a null mutation in 
the gene encoding the conserved helix-loop-helix ubiquitous kinase CHUK, 
also known as IκB kinase α (IKKα). This study has brought significant new 
information about the molecular background of these three lethal fetal 
syndromes, as well as provided knowledge about the prerequisites of 
normal human development. 
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Abstract 
 
Heidi Nousiainen. Molecular Background of Three Lethal Fetal Syndromes. 
National Institute for Health and Welfare (THL), Research 55/2011. 142 pages. 
Helsinki, Finland 2011.  
ISBN 978-952-245-453-9 (printed), ISBN 978-952-245-454-6 (pdf) 
 
This study identified the molecular defects underlying three lethal fetal syndromes. 
Lethal Congenital Contracture Syndrome 1 (LCCS1, MIM 253310) and Lethal 
Arthrogryposis with Anterior Horn Cell Disease (LAAHD, MIM 611890) are fetal 
motor neuron diseases. They affect the nerve cells that control voluntary muscle 
movement, and eventually result in severe atrophy of spinal cord motor neurons and 
fetal immobility. Both LCCS1 and LAAHD are caused by mutations in the GLE1 
gene, which encodes for a multifunctional protein involved in posttranscriptional 
mRNA processing. LCCS2 and LCCS3, two syndromes that are clinically similar to 
LCCS1, are caused by defective proteins involved in the synthesis of inositol 
hexakisphosphate (IP6), an essential cofactor of GLE1. This suggests a common 
mechanism behind these fetal motor neuron diseases, and along with accumulating 
evidence from genetic studies of more late-onset motor neuron diseases such as 
Spinal muscular atrophy (SMA) and Amyotrophic lateral sclerosis (ALS), implicates 
mRNA processing as a common mechanism in motor neuron disease pathogenesis. 
 
We also studied gle1-/- zebrafish in order to investigate whether they would be a 
good model for studying the pathogenesis of LCCS1 and LAAHD. Mutant zebrafish 
exhibit cell death in their central nervous system at two days post fertilization, and 
the distribution of mRNA within the cells of mutant zebrafish differs from controls, 
encouraging further studies. 
 
The third lethal fetal syndrome is described in this study for the first time. Cocoon 
syndrome (MIM 613630) was discovered in a Finnish family with two affected 
individuals. Its hallmarks are the encasement of the limbs under the skin, and severe 
craniofacial abnormalities, including the lack of skull bones. We showed that 
Cocoon syndrome is caused by a mutation in the gene encoding the conserved helix-
loop-helix ubiquitous kinase CHUK, also known as IκB kinase α (IKKα). The 
mutation results in the complete lack of CHUK protein expression. CHUK is a 
subunit of the IκB kinase enzyme that inhibits NF-κB transcription factors, but in 
addition, it has an essential, independent role in controlling keratinocyte 
differentiation, as well as informing morphogenetic events such as limb and skeletal 
patterning. CHUK also acts as a tumor suppressor, and is frequently inactivated in 
cancer. This study has brought significant new information about the molecular 
background of these three lethal fetal syndromes, as well as provided knowledge 
about the prerequisites of normal human development.  
 
Keywords: LCCS1, LAAHD, GLE1, motor neuron, Cocoon syndrome, CHUK, fetal 
development, developmental disorder, Finnish disease heritage 
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Tiivistelmä 
Heidi Nousiainen. Molecular Background of Three Lethal Fetal Syndromes 
[Kolmen letaalin sikiöaikaisen oireyhtymän molekyylitausta]. Terveyden ja hyvin-
voinnin laitos (THL), Tutkimus 55/2011. 142 sivua. Helsinki 2011.  
ISBN 978-952-245-453-9 (printed), ISBN 978-952-245-454-6 (pdf) 
 
Tässä väitöskirjatyössä tunnistettiin kolmen sikiökautena kuolemaan johtavan sai-
rauden aiheuttavat perimän muutokset. Hervan tauti eli Letaali synnynnäinen kont-
raktuuraoireyhtymä (LCCS1, MIM 253310) ja Vuopalan tauti eli Letaali selkäyti-
men etusarvitauti (LAAHD, MIM 611890) ovat liikehermosairauksia, jotka johtavat 
kuolemaan jo kohdussa tai pian syntymän jälkeen. Väitöskirjatyössä osoitettiin, että 
sekä Hervan tauti että Vuopalan tauti aiheutuvat GLE1-geenin virheistä. Solubio-
logisten tutkimusten perusteella tiedetään, GLE1-proteiinilla on solussa keskeinen 
tehtävä lähetti-RNA:n prosessoinnissa. Viime vuosina tehdyt geenilöydökset viit-
taavat siihen, että lähetti-RNA:n prosessointiin liittyvät häiriöt ovat taustalla myös 
muissa liikehermosoluja rappeuttavissa sairauksissa. Väitöskirjatyössä tutkittiin 
myös gle1-geenin suhteen mutantteja seeprakaloja ja todettiin, että kaloilla on kah-
den vuorokauden iässä solukuolemaa keskushermoston alueella ja lähetti-RNA:n 
jakauma solussa on epänormaali. 
 
Lisäksi tässä työssä kuvattiin ensimmäistä kertaa kokonaan uusi oireyhtymä, jossa 
sikiön raajat ovat koteloituneet ihon sisälle ja pään sekä kasvojen alueen rakenne on 
epämuodostunut. Oireyhtymä kuvattiin yhdessä suomalaisessa perheessä, jossa oli 
kaksi sairasta sikiötä, ja sen aiheuttava perimän muutos tunnistettiin CHUK-geenistä. 
Uuden oireyhtymän nimeksi annettiin Cocoon-oireyhtymä (MIM 613630) (engl. 
cocoon = kotelo, suojakalvo). 
 
Väitöskirjatyö on tuottanut merkittävää uutta tietoa sikiöaikaisten kuolemaan johta-
vien sairauksien syntymekanismeista sekä myös normaalin kehityksen edellytyksistä. 
 
Avainsanat: LCCS1, LAAHD, GLE1, liikehermosolu, Cocoon-oireyhtymä, CHUK, 
sikiönkehitys, kehityshäiriö, suomalainen tautiperintö 
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Abbreviations 
ALS Amyotrophic lateral sclerosis 
AO Acridine orange 
BMP Bone morphogenic protein 
cDNA complementary DNA 
CHUK conserved helix-loop-helix ubiquitous kinase 
CNS central nervous system 
CNV copy number variation 
DNA deoxyribonucleic acid 
EJC Exon junction complex 
ES cell embryonic stem cell 
FADS fetal akinesia deformation sequence 
FDH Finnish disease heritage 
FGF Fibroblast growth factor 
HGP Human genome project 
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HSP Hereditary spastic paraplegia 
IBD identical by descent 
IP6 inositol hexakisphosphate 
IKKα Inhibitor of kappa B (IκB) kinase α; also known as IKK1 and 
CHUK 
LAAHD Lethal arthrogryposis with anterior horn cell disease 
LCCS1 Lethal congenital contracture syndrome 1 
LCCS2 Lethal congenital contracture syndrome 2 
LCCS3 Lethal congenital contracture syndrome 3 
LMN lower motor neuron 
LOD logarithm of odds 
Mb megabase 
MIM Mendelian inheritance in man 
MND motor neuron disease 
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MKS Meckel syndrome 
mRNP messenger ribonucleoprotein particle 
NGF Nerve growth factor 
NFκB nuclear factor kappaB 
NMD nonsense mediated mRNA decay 
kb kilobase 
LD linkage disequilibrium 
mRNA messenger RNA 
PCR polymerase chain reaction 
PIP phosphoinositide 
PLC phospholipase C 
PLS Primary lateral sclerosis 
PTC premature termination codon 
PTEN phosphatase and tensin homolog 
PTU 1-phenyl 2-thiourea 
RNA ribonucleic acid 
SBMA Spinal bulbar muscular atrophy 
SCC squamous cell carcinoma 
SMA Spinal muscular atrophy 
SNP single nucleotide polymorphism 
SOD1 superoxidase dismutase 1 
UMN upper motor neuron
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1 Introduction 
The molecular background of lethal fetal syndromes is an interesting and important 
research topic for numerous reasons. First and foremost, parents that have lost a 
child, or often several children to such a disease, benefit from any information that 
can be provided to them about the condition in their family. Once a causative 
mutation for a syndrome is found, DNA testing can immediately be applied in its 
diagnostics. In addition, deciphering the cellular processes that are disturbed in these 
developmental disorders also provide invaluable information about the prerequisites 
of normal human development, and ultimately, increase our knowledge of biology in 
general. Finally, knowledge gained from the study of these rare syndromes often 
benefits the research of more common diseases that are linked to the same organ 
system, cell type, or molecular pathway. 
 
This research focused on three lethal fetal syndromes; two of which are well-
established clinical entities, and one, which we describe here for the first time. 
Lethal Congenital Contracture Syndrome 1 (LCCS1, MIM 253310) and Lethal 
Arthrogryposis with Anterior Horn Cell Disease (LAAHD, MIM 611890) are fetal 
motoneuron diseases. They affect the nerve cells that control voluntary muscle 
movement, and eventually result in severe atrophy of spinal cord motoneurons and 
fetal immobility. Both are inherited in an autosomal recessive manner, and are more 
common in Finland than elsewhere in the world. They represent the most extreme 
end in a spectrum of Motor Neuron Diseases (MNDs), an etiologically 
heterogeneous group of disorders perpetually under intensive research effort. The 
third condition studied here is a fetal encasement malformation found in one family 
of Finnish origin. The first pregnancy of the family ended in miscarriage, and 
multiple fetal malformations were seen in two consecutive pregnancies, which were 
terminated. The most prominent features of the affected fetuses were the encasement 
of the limbs under the skin, and severe craniofacial abnormalities, including the lack 
of skull bones. 
 
The aim of this study was to identify the molecular defects underlying LCCS1 and 
LAAHD, and to describe in detail the novel fetal encasement syndrome, and 
investigate its molecular background. 
 
2 – Review of the literature 
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2 Review of the literature 
2.1 The Finnish Disease Heritage 
 
The Finnish Disease Heritage (FDH), a concept first introduced by Perheentupa 
(Perheentupa 1972) and Norio (Norio et al. 1973), refers to a group of inherited 
conditions that are, in proportion to population size, more common in Finland than 
elsewhere in the world. Currently 36 individual diseases fulfill this definition. 32 of 
these are inherited in an autosomal recessive manner, two are autosomal dominant, 
and two are X-chromosomal (Norio 2003c). The fact that these hereditary diseases 
are found in Finland, while others, such as phenylketonuria and cystic fibrosis are 
not, does not imply that Finns are less healthy than other nations; it merely reflects 
the uniqueness of the Finnish population (Norio 2003a). It is possible that the 
number of FDH diseases will increase in the future; not by the means of Finns 
getting sicker, but through careful evaluation of novel clinical entities, that might 
eventually fit the definition of a FDH disease. The acceptance of a novel syndrome 
into the Finnish disease heritage is usually done through mutual agreement of the 
FDH research community. As a general rule, a minimum of ten individual families 
has to be known for a given disease (Norio. 2000d).  
 
The roots of the FDH lie in the Finnish population history. It has been estimated that 
Finland was first inhabited some 10,000 years ago, after the Late Glacial Maximum 
(Nunez 1987, Norio 2003b). Due to geographical and cultural isolation, migration 
has been exiguous. During the course of history, the population has been shaped by 
both local and national bottlenecks, and has eventually grown to its current size of 
over five million individuals. Up to the 16th century, the habitation was situated 
mainly along the coastline (currently referred to as the early settlement region), until 
the political actions of King Gustavus of Wasa induced an internal migration 
towards the then uninhabited central, eastern, and northern parts of the country. 
These areas now constitute the so-called late settlement region. The majority of 
these late settlers originated from southern Savo (Figure 1), and established local 
communities, which became subisolates as they remained separate from each other 
due to long distances and low population density (De la Chapelle 1993, Peltonen et 
al. 1999, Norio 2003b). This settlement history is still reflected in the genetic 
architechture of Finns, not only in terms of disease, but also in the general 
population (Jakkula et al. 2008, Salmela et al. 2008). The population of each 
subisolate carried their own unique set of genes, including disease mutations. 
Consanguineous marriages were unavoidable in these regional subisolates, although 
2 – Review of the literature 
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the relations between individuals usually dated back several generations, and the 
couples themselves were unaware of them (Norio 2003a). This led to clustering of 
certain diseases in certain parts of the country. During the 20th century the 
population distribution of Finland underwent changes, and settlement concentrated 
increasingly in urban communities. Thus cases of the FDH no longer manifest solely 
in particular regions, but are found throughout the country. However, the birthplaces 
of the greatgrandparents of the cases still show regional clustering in many of the 
diseases, reflecting the historical migration of the Finnish population (Varilo 1999, 
Norio 2003c). Albeit being overrepresented in relation to population size on a global 
scale, the FDH diseases are rare also in Finland, with incidences of the diseases 
varying between 1:8,000 and 1:100,000. This means that approximately six to eight 
cases suffering from a given disease are born each year. Although the disease 
spectrum of FDH covers several branches of medicine, it is most distinctly visible in 
pediatrics. Many of the diseases result in severe handicap and are a heavy burden to 
the patient and family, but some diseases can be treated simply and effectively once 
a correct diagnosis is established (Norio 2003a).  
 
 
 
 
Figure 1. A model for the internal population migration of Finland that occurred in the 16th century. 
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The molecular genetics of the FDH is well studied, and the genetic defect for all of 
the diseases, except for one, has now been published (Table 1). In most diseases, one 
founder mutation accounts for >90% of the cases. However, in some diseases the 
founder mutation is present only in 70-80% of the cases and additional mutations of 
the same gene are found in varying frequencies (Sankila et al. 1992, Kestilä et al. 
1998, Huopaniemi et al. 1999). Even locus heterogeneity within the Finnish 
population has been observed, namely in Meckel syndrome, in which mutations in 
three different loci have been identified in Finnish cases, and additional loci are 
likely to be discovered (Kyttälä et al. 2006, Tallila et al. 2008, Tallila et al. 2009). A 
database of the Finnish diseases and mutations can be found online 
(www.findis.org).  
 
Of the 32 recessive diseases of the FDH, five are invariably lethal during the 
embryonic period or soon after birth. Meckel syndrome (MKS, MIM 249000) and 
Hydrolethalus syndrome (HLS, MIM 236680), which are the most common of the 
embryonically lethal FDHs with incidences of 1:9,000 and 1:20,000, respectively, 
are both characterized by severe malformations of multiple organs, including the 
digits and central nervous system. In addition, large, polycystic kidneys are seen in 
Meckel syndrome. The genetic defect has been identified in both syndromes, 
enabling the use of DNA testing in diagnostics, as well as further studies on the 
molecular background of these disorders (Mee et al. 2005, Kyttälä et al. 2006, 
Tallila et al. 2008). Studies suggest that at least Meckel syndrome, or possibly both 
MKS and HLS, are linked to ciliary dysfunction (Dammermann et al. 2009, Gerdes 
et al. 2009). In addition, studies on the HYLS1 protein, which is defective in HLS, 
implicate altered lipid metabolism, cell cycle regulation, and signalling in the 
pathogenesis of HLS (Honkala et al. 2009). Another neonatally lethal disease of the 
FDH is GRACILE syndrome (MIM 603358), which is characterized by growth 
retardation, aminoaciduria, cholestasis, iron overload, and lactacidosis. GRACILE 
syndrome is caused by the defective mitochondrial inner membrane protein BCS1L, 
although there is some question whether the disease pathogenesis has to do with 
mitochondrial dysfunction, or another, currently uncharacterized cellular function on 
BCS1L, putatively associated with iron metabolism (Visapää et al. 2002). The 
incidence of GRACILE is 1:47,000. The two remaining lethal disorders, Lethal 
congenital contracture syndrome and Lethal arthrogyposis with anterior horn cell 
disease, will be discussed in detail in section 2.3. 
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Table 1. Diseases of the Finnish disease heritage. A reference is given for the first publication(s) of a 
Finnish mutation for each disease, except PEHO, for which the causative mutation has not yet been 
published, and for which a reference of the decription of the phenotype is given. 
Name of the disease  MIM  Symbol  Reference 
Recessive:         
Aspartylglucosaminuria  208400  AGU  (Ikonen et al. 1991) 
Autoimmune polyendocrinopathy‐
candidiasis‐ectodermal dystrophy 
240300  APECED  (Nagamine et al. 1997, The 
Finnish German APECED 
Consortium 1997) 
Cartilage‐hair hypoplasia  250250  CHH  (Ridanpää et al. 2001) 
Cohen syndrome  216550  COH1  (Kolehmainen et al. 2003) 
Congenital chloride diarrhea  214700  CLD  (Höglund et al. 1996) 
Congenital lactase deficiency  223000  –  (Kuokkanen et al. 2006) 
Congenital nephrosis  256300  CNF  (Kestilä et al. 1998) 
Cornea plana congenita   217300  CNA2  (Pellegata et al. 2000) 
Diastrophic dysplasia  222600  DTD  (Hästbacka et al. 1994) 
Finnish variant of late infantile 
neuronal ceroid lipofuscinosis 
256731  vLINCL  (Savukoski et al. 1998) 
FSH‐resistant ovaries  233300  FSH‐RO  (Aittomäki et al. 1995) 
GRACILE syndrome  603358  GRACILE  (Visapää et al. 2002) 
Gyrate atrophy of choroid and retina  258870  GA  (Mitchell et al. 1988) 
Hydrolethalus syndrome  236680  HLS  (Mee et al. 2005) 
Infantile neuronal ceroid lipofuscinosis  256730  INCL  (Vesa et al. 1995) 
Infantile onset spinocerebellar ataxia  271245  IOSCA  (Nikali et al. 2005) 
Lethal arthrogryposis with anterior 
horn cell disease 
611890  LAAHD  (Original publication I) 
Lethal congenital contracture syndrome  253310  LCCS  (Original publication I) 
Lysinuric protein intolerance  222700  LPI  (Borsani et al. 1999, 
Torrents et al. 1999) 
Meckel syndrome  249000  MKS  (Kyttälä et al. 2006) 
Mulibrey nanism  253250  MUL  (Avela et al. 2000) 
Muscle‐eye‐brain disease  253280  MEB  (Diesen et al. 2004) 
Neuronal ceroid lipofuscinosis, juvenile  204200  JNCL  (The International Batten 
Disease Consortium 1995) 
Nonketotic hyperglycinemia  605899  NKH  (Kure et al. 1992) 
PEHO syndrome  260565  PEHO  (Salonen et al. 1991) 
Polycystic lipomembranous 
osteodysplasia with sclerosing 
leukoencephalopathy 
221770  PLOSL  (Paloneva et al. 2000) 
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Progressive epilepsy with mental 
retardation 
600143  EPMR  (Ranta et al. 1999) 
Progressive myoclonus epilepsy  254800  EPM1  (Pennacchio et al. 1996, 
Virtaneva et al. 1997) 
RAPADILINO syndrome  266280  RAPADILINO  (Siitonen et al. 2003) 
Selective intestinal malabsorption of 
vitamin B12 
261100  MGA1  (Aminoff et al. 1999) 
Sialic acid storage disease  604369  SD  (Verheijen et al. 1999) 
Usher syndrome, type III  276902  USH3  (Joensuu et al. 2001) 
 
Dominant: 
       
Familial amyloidosis, Finnish type  105120  FAF  (Levy et al. 1990, Maury et 
al. 1990) 
Tibial muscular dystrophy  600334  TMD  (Hackman et al. 2002) 
 
X‐chromosomal: 
       
Choroideremia  303100  CHM  (Sankila et al. 1992) 
Retinoschisis  312700  RS  (The Retinoschisis 
Consortium 1998) 
 
 
The research of the molecular genetics of rare syndromes, such as diseases of the 
FDH, can contribute substantially to the research of more common diseases as well. 
For example, nephrin, a key structural protein of the glomerular podocyte in the 
kidney, was discovered via molecular genetic analysis of patients with Finnish type 
Congenital nephrotic syndrome (CNF) (Kestilä et al. 1998). CNF is rare outside 
Finland, but the interest in nephrin is global, since it is an essential structural protein 
of the kidney and is also involved in important signalling processes. Thus, studies of 
the nephrin protein contribute to understanding the physiology of the kidney in 
health and disease. A particular area of focus is now understanding the role of 
nephrin in the podocyte insulin response and diabetic nephropathy, which is the 
most common cause of endstage renal failure in the Western world and, along with 
the current ‘epidemic’ of obesity and type II diabetes, a rapidly increasing burden on 
both morbidity and health economics (Welsh and Saleem 2010). 
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2.2 Fetal motor neuron disease 
2.2.1 Motor neuron disease 
Motor neuron diseases (MNDs) are an etiologically heterogeneous group of 
disorders that affect the nerve cells controlling voluntary muscle movement. MNDs 
include diseases such as the childhood-onset Spinal muscular atrophy (SMA) and 
the late-onset Amyotrophic lateral sclerosis (ALS). Table 2 lists some motor neuron 
diseases and their clinical characteristics. (Dion et al. 2009)  
 
Table 2. Classification and clinical characteristics of motor neuron diseases, modified from (Dion et al. 
2009).  
Disease  Age of onset  Prevalence  Motor neuron 
involvement 
Clinical features 
ALS  Between 45 and 
60 years old 
4‐6/1000,000  UMNs and 
LMNs 
Progressive muscle 
weakness, atrophy and 
spasticity 
HSP  From early 
childhood to 70 
years old 
3‐10/100,000  UMNs  Progressive spasticity in 
the lower limbs 
PLS  Between 35 and 
66 years old 
1/10,000,000  UMNs  Spinal and bulbar 
spasticity 
SMA  Between 6 and 18 
months old for 
type I, II and III; 
between 15 and 
50 years for type 
IV 
1/6,000‐10,000  LMNs  Symmetrical muscle 
weakness and atrophy 
SBMA  Between 30 and 
50 years old 
1‐9/100,000  LMNs  Slowly progressive limb 
and bulbar muscle 
weakness with 
fasciculations, muscle 
atrophy and 
gynecomastia 
LCCS  Fetal  1/25,000  UMNs and 
LMNs 
Early fetal hydrops and 
akinesia, degeneration 
of anterior horn motor 
neurons and extreme 
skeletal muscle atrophy 
LAAHD  Fetal  >1/100,000  UMNs and 
LMNs 
Fetal akinesia, 
arhtogryposis and motor 
neuron loss. 
 
ALS, amyotrophic lateral sclerosis; HSP, hereditary spastic paraplegia; LAAHD, lethal arthrogryposis with 
anterior horn cell disease; LCCS, lethal congenital contracture syndrome; LMN, lower motor neuron; PLS, 
primary lateral sclerosis; SBMA, spinal bulbar muscular atrophy; SMA, spinal muscular atrophy; UMN, upper 
motor neuron. 
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Approximately 10% of Amyotrophic lateral sclerosis is familial, usually inherited in 
an autosomal dominant manner, although recessive and X-linked forms also exist 
(Bento-Abreu 2010) (Table 3). However, 90% of ALS cases are sporadic with no 
apparent family history. Most of the knowledge of the pathogenesis of ALS comes 
from the study of the rare genetic forms (Bento-Abreu 2010). Superoxidase 
dismutase 1 (SOD1) mutations are the most common cause of familial ALS. SOD1 
mutations are seen in 20% of familial ALS patients, thus explaining 2% of all ALS 
cases. SOD1 is a ubiquitously expressed enzyme that catalyzes the conversion of 
superoxide free radicals to hydrogen peroxide. It is active as a homodimer. Missense 
mutations affecting almost every single one of the 153 amino acid residues 
comprising the SOD1 protein have been found, usually inherited in an autosomal 
dominant form. One particular mutation, D90A, which is common in Finnish ALS 
patients, is found throughout the world and usually inherited in an autosomal 
dominant manner, but in some Finnish and Swedish patients it follows an autosomal 
recessive mode of inheritance (Andersen et al. 1996, Parton et al. 2002). The 
disease-associated haplotype surrounding the recessive and dominant D90A 
mutations is different, suggesting a presence of a modifying genetic factor that could 
explain this difference between recessive and dominant D90A forms (Parton et al. 
2002). Studies on murine models suggest a toxic gain-of-function as the pathogenic 
mechanism behind motor neuron toxicity induced by mutant SOD1 (Reaume et al. 
1996), but despite nearly two decades of intensive research efforts, the mechanism 
by which mutant SOD1 induces motor neuron degeneration remains incompletely 
understood. (Bento-Abreu 2010) 
 
Spinal muscular atrophy (SMA) often refers to the most common form of the 
disease, proximal SMA, caused by loss-of-function mutations in the survival motor 
neuron 1 (SMN1) gene. Proximal SMA results from reduced expression levels of the 
full-lenght SMN protein. SMN is encoded by the SMN1 and SMN2 genes. The 
majority of SMN protein, however, is derived from the SMN1 gene. The SMN2 gene 
contains a translationally silent C-T transition that alters an exonic splice enhancer 
motif and results in the exclusion of exon 7 from most SMN2 transcripts yielding a 
highly unstable SMN protein that is degraded by the ubiquitin-proteasome system 
(Burnett et al. 2009). The SMN protein is widely expressed in different tissues, and 
together with Gemin proteins, it forms a complex that is important in the assembly, 
recycling, and maintenance of small nuclear ribonucleoproteins (snRNPs), 
components of the spiceosome (Kolb et al. 2007). In addition to proximal SMA 
caused by SMN1 mutations, there are multiple forms of SMA that are 
distinguishable by age of onset and molecular background, summarized in Table 4. 
(Wee et al. 2010) 
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In hereditary spastic paraplegias (HSPs), mutations in twenty different genes are 
currently known. The proteins encoded by these genes, and thus implicated in the 
pathogenesis of HSPs, can be grouped into three categories according to their 
cellular functions; membrane traffic -related proteins, mitochondrial proteins, and 
proteins related to myelination (Blackstone et al. 2011). 
 
Primary lateral sclerosis (PLS) is an autosomal disorder that only affects upper 
motor neurons in the corticospinal and corticobulbar tracts. Unlike ALS, lower 
motor neuron involvement in not seen in PLS. However, there are patients who 
present pure upper motor neuron signs for years but later progress to typical ALS, so 
there is some clinical overlap with ALS. The PLS locus has been mapped to 
chromosome 4p (Valdmanis et al. 2008). PLS can also result from ALS2 mutations 
(Dion et al. 2009).  
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Table 3. Genetic background of familial ALS, modified from (Bento-Abreu 2010) 
Type of 
familial 
ALS 
Inheritance  Onset  Chr  Gene  Protein function 
ALS1  AD (AR)  adult  21q  SOD1  Enzyme that catalyses the conversion 
of superoxide free radicals to 
hydrogen peroxide 
 
ALS2* 
 
AR 
 
childhood 
 
2q 
 
ALS2 
 
Functions as a guanine nucleotide 
exchange factor for the small GTPase 
RAB5. Localizes with RAB5 on early 
endosomal compartments, and 
functions as a modulator for 
endosomal dynamics. 
ALS3  AD  adult  18q  ?   
ALS4  AD  childhood/ 
adolescent 
9q  SETX  Contains a C‐terminal DNA/RNA 
helicase domain suggesting 
involvement in both DNA and RNA 
processing 
ALS5  AR  childhood  15q  ?   
ALS6  AD (AR)  adult  16p  FUS  Involved in RNA processing 
ALS7  AD  adult  20p  ?   
ALS8*  AD  adult  20q  VAPB  Type IV membrane protein found in 
plasma membranes and intracellular 
vesicle membranes 
 
ALS9 
 
AD 
 
adult 
 
14q 
 
ANG 
 
Hydrolyzes cellular tRNAs resulting in 
decreased protein synthesis. 
Angiogenin mediates the formation 
of new blood vessels. 
 
ALS10 
 
AD 
 
adult 
 
1p 
 
TARDBP 
 
DNA and RNA binding protein 
 
ALS11 
 
AD 
 
adult 
 
6q 
 
FIG4 
 
Contains SAC domain that has 
phosphoinositide phosphatase 
activity 
 
*ALS2 is allelic with PLS 
*ALS8 is allelic with Adult onset proximal SMA 
AR = autosomal recessive, AD = autosomal dominant
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Table 4. Genetic background of SMA, modified from (Wee et al. 2010) 
Type of SMA  Inheritance  Onset  Chr  Gene  Protein function 
           
Proximal SMAs           
 
Proximal spinal 
muscular atrophy 
 
AR 
 
infantile/ 
childhood 
 
5q 
 
SMN1 
 
Forms heteromeric 
complexes with proteins 
such as SIP1 and GEMIN4, 
and also interacts with 
several proteins known to 
be involved in the 
biogenesis of snRNPs. 
Infantile SMA with 
arthrogryposis 
X‐linked  infantile  Xp  UBA1  Catalyzes the first step in 
ubiquitin conjugation to 
mark cellular proteins for 
degradation 
SMA with 
pontocerebellar 
hypoplasia 
AR  congenital/ 
infantile 
14q  VRK1  Member of the vaccinia‐
related kinase (VRK) family 
of serine/threonine 
protein kinases potentially 
involved in regulating cell 
proliferation. 
SMA type I 
phenotype due to 
mitochondrial 
dysfunction 
AR  infantile/ 
childhood 
22q  SCO2  An assembly factor for the 
multimeric cytochrome c 
oxidase (COX) protein 
complex. COX is involved 
in aerobic ATP production. 
Spinal and bulbar 
muscular atrophy 
(SBMA) 
X‐linked  adult  Xq  Androgen 
receptor 
Steroid‐hormone 
activated transcription 
factor 
Adult onset 
proximal SMA* 
AD  adult  20q  VAPB  Type IV membrane protein 
found in plasma 
membranes and 
intracellular vesicle 
membranes 
Distal SMAs or hereditary motor neuropathies (HMNs) 
HMN 2A  AD  adult  12q  HSPB8  Belongs to the superfamily 
of small heat‐shock 
proteins containing a C‐
terminal alpha‐crystallin 
domain 
HMN 2B  AD (AR)  adult  7q  HSPB1  Stress resistance and actin 
organization 
HMN 2C  AD  adult  5q  HSPB3  Muscle‐specific small heat 
shock protein 
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HMN 4  AR  childhood  1p  PLEKHG5  Activates the nuclear 
factor kappa B (NFKB1) 
signaling pathway 
 
HMN 5A 
 
AD 
 
adult 
 
7p 
 
GARS 
 
Glycyl‐tRNA synthetase 
HMN 5B  AD  variable  11q  BSCL2  ER‐localized protein 
HMN 7B  AD  adult  2p  DCTN1  The largest subunit of 
dynactin, a 
macromolecular complex 
that binds to microtubules 
and cytoplasmic dynein. 
Dynactin is involved in ER‐
to‐Golgi transport, the 
centripetal movement of 
lysosomes and 
endosomes, spindle 
formation, chromosome 
movement, nuclear 
positioning, and 
axonogenesis. 
Scalpuloperoneal 
SMA (SPSMA) 
AD  congenital  12q  TRPV4  Ca2+‐permeable, 
nonselective cation 
channel that is thought to 
be involved in the 
regulation of systemic 
osmotic pressure. 
Distal SMA,  
X‐linked 3 
X‐linked  variable  Xq  ATP7A  Transmembrane protein 
that functions in copper 
transport across 
membranes. 
SMN with 
respiratory distress 
1 (SMARD1, HMN 
6) 
AR  infantile  11q  IGHMBP2  Helicase superfamily 
member that binds a 
specific DNA sequence 
from the immunoglobulin 
mu chain switch region. 
*Adult onset proximal SMA is allelic with ALS8 
AR = autosomal recessive, AD = autosomal dominant
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2.2.2 Fetal akinesia deformation sequence (FADS) 
Pena and Shokeir were the first to describe patients with a lethal syndrome of 
multiple joint contractures, characteristic facial features including a small chin and 
low-set ears, and pulmonary hypoplasia (Pena and Shokeir 1974). It was 
subsequently suggested that the Pena-Shokeir phenotype is not specific enough to 
delineate one syndrome, but rather a general, secondary phenotype resulting from 
decreased or absent fetal movement in utero (Moessinger 1983, Hall 1986, 
Hageman et al. 1987), and is therefore currently referred to as the Fetal Akinesia 
Deformation Sequence (FADS). FADS can be caused by extrinsic factors, such as a 
maternal tumor, oligohydramnion, or myasthenia gravis, or intrinsic factors, such as 
fetal muscle-, nerve- or connective tissue disease (Spranger et al. 1982). 
2.2.3 Lethal Congenital Contracture Syndrome 1 (LCCS1) 
Lethal congenital contracture syndrome 1 (LCCS1, MIM 253310) is an autosomally 
recessively inherited fetal motoneuron disease. The disease was first described by 
Dr. Riitta Herva, a pathologist working at the Oulu University Hospital, and is also 
referred to as Herva disease (Herva et al. 1985). LCCS1 was previously called 
LCCS, but in 2007 Narkis and colleagues published the causative genes for two 
syndromes that they called LCCS2 and LCCS3 (Narkis et al. 2007a, Narkis et al. 
2007b) (see section 2.2.5.), and thus the name of LCCS was also amended as 
LCCS1 in 2008 (Original publication I). LCCS1 can be detected relatively early on 
in the pregnancy; using modern ultrasonogram equipment a diagnosis can be made 
already during the 11th-12th gestational week. The LCCS1 fetus is small for 
gestational age and completely immobile with flexion contractures of the elbows, 
wrists, and hips, and hyperextension of the knees. Other clinical characteristics 
include pterygia of the elbows and the neck, pulmonary hypoplasia, and typical 
facial features including eyes that are wide apart, low set ears, and a small chin 
(micrognathia). In addition to these clinical features consistent with the FADS 
phenotype, severe hydrops of the fetus is also seen. In the case of LCCS1, the 
immobility and associated FADS phenotype is caused by the extreme atrophy of 
spinal cord motoneurons, which can be verified at autopsy (Herva et al. 1988). Also 
extreme atrophy of skeletal muscles is seen. However, other internal organs, 
including the brain, appear macroscopically normal. A histological cross section of 
the spinal cord is needed in order to establish a correct diagnosis. 
 
The LCCS1 locus was mapped to chromosome 9q34 by linkage in 1998. The inital 
scan using five affected individuals pointed out four chromosomal loci which were 
identical by descent in all of the affected individuals, but the analysis of a denser 
marker set in ten families with a total of 20 affected individuals excluded all of these 
except the region in chromosome 9. The multipoint linkage analysis yielded a 
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maximum LOD score of 6.5, which peaked between the markers D9S1825 and 
D9S1830 (Mäkelä-Bengs et al. 1998). One core haplotype segregating with the 
disease was observed in the LCCS1 families. By analysis of multiallelic markers in 
LCCS1 family material the critical chromosomal region was further defined between 
markers D9S1827 and D9S752 based on recombinations in the shared ancestral 
haplotype. This was done at a time when the genetic map of the region was not yet 
completed. Sequencing of 18 of the genes within proximity of the region revealed no 
pathogenic mutations (Pakkasjärvi 2005b). Upon the completion of the Human 
Genome Project (see section 2.4.1) the genetic map of the LCCS1 locus was 
finalized, and thus the exact defining of the region as well as systematic analysis of 
all the regional candidate genes was facilitated. 
 
To further investigate the molecular background of LCCS1, the RNA expression 
profiles of the spinal cords of LCCS1 fetuses and age-matched controls were 
compared using the Affymetrix HG-U133A expression arrays. Differentially 
expressed genes included a total of 34 downregulated transcripts and three 
upregulated transcripts (Pakkasjärvi et al. 2005a). Grouping of differentially 
expressed genes according to biological process revealed nine categories that were 
significantly different in LCCS1 fetuses and controls. These were: neurogenesis, 
synaptic transmission, transmission of nerve impulse, nerve ensheathment, neuronal 
maturation, central nervous system development, organogenesis, morphogenesis, 
and cholesterol biosynthesis. OLIG2, a transcription factor that controls motor 
neuron differentiation in the ventral spinal cord, and ERBB3, a protein that is crucial 
for the development of Schwann cells (see section 2.2.5.2), were among the 
transcripts downregulated in LCCS1 fetuses. Based on these observations, it was 
suggested that motor neuron degeneration in LCCS1 could be due to 
oligodendrocyte dysfunction. Also the transcription factor NKX2.2 showed marginal 
downregulation in LCCS1 spinal cords. In addition, marginal upregulation of PAX6 
and GLI2 was observed. (Pakkasjärvi et al. 2005a) OLIG2, NKX2.2, PAX6, and 
GLI2 are all involved in the development of motor neurons from the ventral neural 
tube (see section 2.4.1). 
 
Neural precursor cells from LCCS1 fetuses and age-matched controls were cultured 
in vitro to investigate their ability to differentiate into distinct neuronal subtypes. 
The LCCS1 cells were able to differentiate into oligodendrocytes, astrocytes, and 
motor neurons, expressing the appropriate neuronal markers, suggesting that the 
atrophy of motor neurons in LCCS1 patients is not due to defects in neuronal 
differentiation, but rather defects in cell survival (Pakkasjärvi et al. 2007). No 
significant differences in the amount of apoptotic or necrotic cells were observed 
between the LCCS1 and control cell cultures. However, the global transcription 
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profiles of the LCCS1 cells and control cells differed from each other. The EGFR 
transcript was among the genes upregulated in LCCS1 cells. EGFR levels are known 
to determine progenitor cell proliferation and differentiation, potentially suggesting 
increased proliferation of the LCCS1 cells. Indeed, the LCCS1 cells appeared denser 
in culture, but statistical testing revealed no significant difference between 
proliferative activity of LCCS1 and control cells. It has to be noted that control cells 
and LCCS1 cells were harvested on separate occasions, and although care was taken 
to ensure consistency in the harvesting of cells, factors such as the difficulty to 
assess the exact time of death of the fetus from which the cells were harvested may 
account for differences in their respective abilities to thrive in culture. 
2.2.4 Lethal arthrogryposis with anterior horn cell disease (LAAHD) 
Lethal arthrogryposis with anterion horn cell disease (LAAHD, MIM 611890) was 
first described by Dr. Katri Vuopala, and is commonly referred to as the Vuopala 
disease. The clinical findings in LAAHD are very similar to LCCS1, only slightly 
less severe. Fetal movement can be seen in the ultrasonogram investigation in the 
beginning of the second trimester of the pregnancy, but movements decrease during 
the course of the pregnancy. Contrary to LCCS1, no fetal hydrops is seen, but 
polyhydramnion has been reported in many of the pregnancies. The fetuses have 
malpositions in the extremities; the wrists and ankles are turned inwards. Diagnosis 
by ultrasound examination is possible in some cases. A report from 1995 describes 
eleven LAAHD families; in these, 53% of the affected fetuses were born at term and 
40% prematurely. The mean duration of pregnancy was 34 weeks. 33% of the 
fetuses were small for gestational age. Three infants were stillborn, five died within 
an hour from birth, six lived for a few days, and one infant survived for twenty days 
(Vuopala et al. 1995). The longest survival for a LAAHD patient has been two 
months (Dr. Herva, personal communication). The LAAHD patients have 
hypoplastic lungs, and the primary cause of death after birth is respiratory 
insufficiency. Analysis of skeletal muscle of ten LAAHD cases showed variation in 
pathological findings; minor changes were seen in four infants, while in the 
remaining six infants, more distinct groups of atrophic fibers and hypertrophic type 
1 fibers were seen (Vuopala et al. 1995). Analysis of a distal muscle sample from 
one affected infant showed severe neurogenic atrophy. The gross anatomy of the 
brain was normal, and myelination was normal with respect to gestational age. The 
motor neurons of the anterior horn of the spinal cord were degenerated and 
diminished in number. 
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Figure 2. Left: A LCCS1 fetus (23 weeks) with typical malpositions of the arms and legs, joint 
contractures and micrognathia. Right: A baby with LAAHD (38 weeks) displaying typical malpositions 
of the wrists and ankles. 
 
2.2.5 LCCS2 and LCCS3 
In 2003, Landau and colleagues reported 23 patients with a syndrome of congenital 
contractures from a large, inbred Israeli-Bedouin kindred. In two of these cases, the 
pregnancies ended prematurely at 23 and 26 weeks, respectively, but the rest were 
carried to term. No fetal hydrops was observed. The newborns were small for 
gestational age and displayed multiple joint contractures along with severe muscle 
atrophy of the lower limbs, but lacked pterygia. In 12 cases, an enlarged urinary 
bladder was observed. Five cases had hydronephrosis and cystic changes of the 
kidneys. Of the 23 cases, one pregnancy was terminated, three infants were stillborn, 
11 died shortly after birth, four newborns survived up to two weeks, one to one 
month, and one to one year of age. Two girls, aged 12 and 13 years, were still alive 
at the time of publication of the article. An autopsy was performed on two patients, 
and atrophy of the anterior horn of the spinal cord was reported in one of them. 
Muscle biopsies performed on three cases suggested neurogenic muscle atrophy. 
(Landau et al. 2003) Despite the fact that two patients were still alive at 12 and 13 
years of age, respectively, the syndrome was defined as Lethal congenital 
contracture syndrome type 2 (LCCS2, MIM 607598) (Narkis et al. 2004). 
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Linkage to the Spinal Muscular Atrophy (SMA) locus on chromosome 5q and the 
LCCS1 locus on chromosome 9q34 were excluded (Landau et al. 2003). The LCCS2 
locus was assigned to a 6.4 Mb interval on chromosome 12q13 by homozygosity 
mapping using DNA samples from 10 affected and 44 unaffected members of the 
consanguineous Bedouin tribe (Narkis et al. 2004). The critical chromosomal region 
was further narrowed down to 4.6 Mb, and sequencing of the regional candidate 
genes in affected individuals and controls revealed that a frameshift-inducing 
intronic mutation in the ERBB3 gene (NM_001982) segregated with the disease 
(Narkis et al. 2007b).  ERBB3 encodes for an epidermal growth factor (EGF) 
receptor ERBB3 (HER3), consisting of a polypeptide of 1342 amino acids, but the 
mutation predicts a truncated polypeptide of 399 amino acids. 
 
LCCS3 is another fetal akinesia phenotype found in Israeli-Bedouin kindreds. The 
affected newborns are small for gestational age with multiple joint contractures and 
muscle atrophy of the lower limbs. Of the nine pregnancies reported, four were 
terminated on the basis of ultrasonographic findings of fetal akinesia and limb 
contractures. Two infants were born at 29 gestational weeks, and three at term. All 
of these infants died shortly after birth. None of the families agreed to post-mortem 
examination, so there is no information available on the histolopathology of the 
spinal cord or skeletal muscle (Narkis et al. 2007a). By analyzing the DNA of five 
affected and 25 unaffected individuals, the LCCS3 disease gene was mapped to a 
8.8 Mb interval on chromosome 19p13. Sequencing of 30 out of a total of 120 
regional candidate genes suggested a missense mutation in exon 7 of the PIP5K1C 
gene (NM_012398) as being the causative mutation for LCCS3. The mutation 
(c.757G>A) results in the substitution of aspartic acid to asparagine (p.253D>N) in 
the PIP5K1C polypeptide (Narkis et al. 2007a).  PIP5K1C (PIPKIγ) is a member of 
the PIP kinase type I (PIPKI) family of enzymes. It phosphorylates the fifth 
hydroxyl group of phosphatidylinositol-4-phosphate (PI-4-P) to generate 
phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2). Narkis and colleagues assayed 
the kinase activity of the mutant and wild type PIP5K1C enzymes in vitro by 
generating recombinant proteins from cDNA obtained from fibroblast cells of 
LCCS3 patients and controls, respectively. PI-4-P was used as a substrate, and 
[γ32P]ATP was provided in the reaction mix. Quantification of the labeled end 
product, PI-4,5-P2 showed that the mutant protein was only able to generate 
approximately 1,7% of the amount of PI-4,5-P2 generated by the wild type protein 
(Narkis et al. 2007a). 
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2.2.5.1 ERBB3 and PIP5K1C are associated with phosphoinositide 
synthesis 
Phosphoinositides (PIPs) are small signalling molecules that participate in a variety 
of cellular processes. They regulate vesicular trafficking, and also modulate lipid 
distribution and metabolism via lipid transfer proteins. In addition, they regulate ion 
channels, pumps, and transporters, as well as endocytic and exocytic processes 
(Balla et al. 2009). The various phosphoinositides are formed by a large number of 
kinases and phosphatase enzymes. Members of the phospholipase C (PLC) enzyme 
family cleave the phosphatidyl group of phosphatidylinositol 4,5-bisphosphate (PI-
4,5-P2) resulting in the formation of inositol 1,4,5-trisphosphate (IP3), which in turn 
is a precursor for another important group of molecules, the inositol polyphosphates 
(IPs). The inositol polyphosphates play an important role in nuclear processes such 
as transcription control, mRNA export, and DNA repair, and are also critical for 
development and signaling (Tsui and York 2010). As one review sums up the 
importance of these molecules: ”It might be easier at this time to list the processes 
that are not regulated by inositides in an eukaryotic cell than those that are clearly 
inositide dependent” (Balla et al. 2009).  
 
PIP5K1C (PIPKIγ), which is defective in LCCS3 patients, is a member of the PIP 
kinase type I (PIPKI) family of enzymes. PIP type I kinases synthesize 
phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2) by phosphorylating the fifth 
hydroxyl group of phosphatidylinositol-4-phosphate (PI-4-P) (Anderson et al. 1999). 
The three isoforms of type I phosphatidylinosito-4-phosphate-5-kinase (PIP5K1A, 
PIP5K1B, and PIP5K1C) are encoded by three separate genes. Although they are all 
capable of synthesizing PIP2, these enzymes have different primary structures, 
distinct expression levels in different tissues, and localize within different 
compartments of cells, which suggests that they are likely to have overlapping, but 
not identical functions (Wang et al. 2007). PIP5K1A is localized in membrane 
ruffles (Doughman et al. 2003), PIP5K1B is located near endosomes (Padrón 2003), 
and PIP5K1C is targeted to focal adhesions and synapses (Wenk et al. 2001, Ling et 
al. 2002, Di Paolo et al. 2004). 
 
ERBB3 is a member of the ERBB (HER) family of receptors that regulate 
mammalian cell survival, proliferation, and differentiation in response to growth 
factors such as epidermal growth factor (EGF) and heregulin (Alroy and Yarden 
1997, Burden and Yarden 1997). ERBB3 binds the regulatory p85 subunit of type 1 
phosphoinositide 3-kinase (PI3K), thus increasing its kinase activity (Hellyer et al. 
1998). Mammals have five distinct p85 isoforms (Vanhaesebroeck et al. 2010), and 
there is some evidence that different p85 isoforms bind different receptors (Xia and 
Serrero 1999, Inukai et al. 2001), but it is not specified in the literature which 
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isoform/isoforms of the p85 subunit were observed to interact with ERBB3 (Holt et 
al. 1994, Hellyer et al. 1998). PI3K type 1 enzymes phosphorylate the 3-hydroxyl 
group of the inositol ring of phosphatidylinositol-4,5-bisphosphate (PI-4,5-P2) 
generating phosphatidylinositol 3,4,5-trisphosphate (PI-3,4,5-P3), which, in turn, is 
then quickly converted by phosphatase enzymes into either PI-3,4-P2 or back to PI-
4,5-P2 (Figure 3). PI3K type 1 enzymes are comprised of two subunits; a regulatory 
subunit, and a catalytic subunit. In mammals, there are numerous isoforms of both 
the regulatory and catalytic subunits encoded by distinct genes, potentially giving 
rise to a number of different enzyme heterodimer molecules (Franke 2008, 
Vanhaesebroeck et al. 2010). The different isoforms of these subunits are 
differentially expressed in cells and tissues (Kok et al. 2009). PI-3,4,5-P3 and PI-3,4-
P2 coordinate the localization and function of multiple effector proteins, including 
Serine/Threonine and Tyrosine protein kinases (Such as AKT and BKT, 
respectively), adaptor proteins (such as GAB2), and regulators of the Rac, Ras, and 
Arf families of small GTPases (Vanhaesebroeck et al. 2010). PTEN acts as a 
negative regulator of PI-3,4,5-P3 levels in the cell, and also functions as a tumor 
suppressor via the AKT/PKB signalling pathway. PTEN is frequently inactivated in 
cancer. Phosphoinositides and the enzymes that phosphorylate and dephosphorylate 
them influence various signalling networks that control cellular processes such as 
growth and proliferation (Figure 4). 
 
 
 
 
 
 
Figure 3. The defective genes in LCCS2 and LCCS3 are both associated with phosphoinositide 
synthesis. 
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Figure 4. Phosphoinositides PIP3 and PIP2 are membrane-bound, whilst the inositol polyphosphates 
(IPs) are soluble. Phosphoinositides and the enzymes that phosphorylate and dephosphorylate them 
influence signalling networks that control cellular processes such as growth and proliferation (Balla et 
al. 2009). 
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2.2.5.2 Erbb3 -/- mice 
Rietmacher and Sonnenberg-Rietmacher generated mice with targeted mutations in 
Erbb3. Heterozygous animals were healthy and fertile, but most homozygous 
embryos died between E11.5 and E13.5. Surviving embryos developed to term, but 
newborn pups did not respond to tactile stimulation, were unable to breathe, and 
died soon after birth. Mutant embryos that were still alive at E16.5, however, did 
respond to tactile stimulation, although spontaneous movement was reduced. 
Histological analysis on homozygous pups at E12.5 showed a presence of sensory 
and motor neurons, but the lack of Schwann-cell precursors that usually accompany 
them. By E18.5, also the number of sensory and motor neurons was markedly 
reduced in mutant embryos. The researchers concluded that in homozygous mutant 
embryos, both sensory and motor neurons start to form, but subsequently 
degenerate, most likely due to the lack of Schwann cells. (Riethmacher and 
Sonnenberg-Riethmacher 1997) 
 
2.2.5.3 Pip5k1c -/- mice 
Two mouse lines with disruptions in the Pip5k1c gene have been generated 
independently by two separate research groups (Di Paolo et al. 2004, Wang et al. 
2007). Notably, these two mouse lines have distinctly different phenotypes.  
 
Exons 2–6 of the murine Pip5k1c gene, which encode most of the catalytic region, 
were deleted by homologous recombination by Di Paolo and colleagues to generate 
Pip5k1c -/- animals. The lack of Pip5k1c expression was verified by immunoblotting. 
Mutant mice are carried to term and are born alive with no obvious anatomical 
anomalies, but die postnatally within 24h, and can be distinguished from wild type 
littermates due to impaired motility and the lack of milk in their stomachs (Di Paolo 
et al. 2004). Analysis of phosphatidylinositol levels in neonatal brain by electrospray 
ionization mass spectrometry (ESI–MS) revealed a 40% reduction in the PIP2 levels 
of Pip5k1c -/- animals. ESI-MS is not able to distinguish between PIP2 isomers (i.e. 
PI-4,5-P2, PI-3,5-P2, PI-3,4-P2), but since the majority of PIP2 in the brain is 
represented by the PI-4,5-P2 isomer (>95%), it was concluded that PIP5K1C has a 
major role in mediating PI-4,5-P2 synthesis in the brain. Pip5k1c-/- neurons 
differentiated in vitro similarly to controls based on the analysis of axonal or 
dendritic processes and of pre- and post-synaptic compartments using specific 
immunocytochemical markers, but synaptic transmission defects were observed 
during high-frequency stimulation. The analysis of synaptic vesicle trafficking 
showed a 20% decrease in the size of the recycling vesicle pool in mutant nerve 
terminals. Measurement of recycling time, i.e. the time that elapses before dye-
loaded endocytic vesicles become available for a new round of exocytosis during 
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continuous stimulation, revealed that mutant nerve terminals were slower in 
regaining release competence in comparison to controls, indicating a delay in 
membrane recycling in the Pip5k1c-/- neurons. An assay for real-time measurement 
of synaptic vesicle exo- and endocytosis indicated that endocytosis was slower in 
mutant neurons during stimulation in relation to exocytosis. Monitoring of clathrin-
mediated endocytosis during stimulation showed that percentage of coated vesicles 
relative to the total number of vesicles was 3.5-fold lower in Pipk1c-/- nerve 
terminals than in control nerve terminals, and was virtually unchanged from the 
resting level, suggesting a defect in the clathrin-dependent reformation of synaptic 
vesicles in mutant animals. (Di Paolo et al. 2004) 
 
Wang and colleagues utilized an ES cell line containing a disruption of the Pip5k1c 
gene generated by β-geo random insertion mutagenesis to create Pip5k1c -/- animals. 
RT-PCR and immunoblot analysis indicated complete loss of the Pip5k1c transcript 
beyond the first exon. Most of the mutant animals die prenatally by embryonic day 
E11.5, although some survive longer (Wang et al. 2007). The mutant embryos are 
small in size, have massively dilated pericardial sacs, and anatomical anomalies of 
the heart. They also exhibit rostral neural tube closure defects (exencelphaly), but 
closure of the caudal neural tube over the spinal cord is complete. Analysis of 
mutant embryos revealed that the telancephalic neural folds failed to close, resulting 
in a disorganized neuroepithelium. 
 
The phenotypic difference between the two Pip5k1c knockout animals could be 
explained by the different genomic background of the two murine strains. Wang and 
colleagues suggest that the observed differences could be due to modifier genes. An 
educating example comes from Kumar and colleagues, who observed a surprising 
phenotype in their knockout animals, and subsequently demonstrated that this 
phenotype was not due to the targeted deletion of their gene of interest, but a single 
mutation in another gene, which existed in their mouse embryonic stem cells even 
before the generation of the knockout mice (Kumar et al. 2004).  Since the lack of 
Pip5k1c expression was verified in both mice, it is a possibility that the difference in 
phenotype is due to another mutation event. Because of the phenotypic difference of 
the two Pip5k1c knockout mice, the results of the studies have to be interpreted 
cautiously, and the role of Pip5k1c gene in synaptic vesicle trafficking and 
embryonic development can still not be stated with certainty. However, some results 
from these studies are pretty straightforward; for example staining for β-gal in 
heterozygous animals generated by Wang and colleagues showed that Pip5k1c is 
expressed most prominently in the motor column and in the developing ascending 
and descending spinal tracts (Wang et al. 2007). 
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2.3 Molecular characterization of diseases 
The first step towards identifying the molecular defect for a disease or a trait is the 
precise assessment of the phenotype, and careful evaluation of the samples with 
regard to the phenotype. Following this, numerous different strategies can be 
utilized to solve the molecular background of the disease. Two main approaches are 
applicable. One way of thinking is to characterize the defective protein product 
through its function by application of biological information; the other is to identify 
the causative gene through its position and sequence within the genome. It is often 
advantageous to consider both. 
2.3.1 Characterization of disease genes through functional studies 
Molecular medicine began with the seminal work of Linus Pauling, who recognized 
a defect in the hemoglobin molecule of patients with sickle cell anemia (Pauling et 
al. 1949), and Vernon Ingram, who showed that this defect was due to a mutation in 
the gene encoding hemoglobin beta (Ingram 1957). This was the first time when a 
single amino acid change in a protein was shown to cause a disorder, and it also 
demonstrated that if the biochemical basis of a condition is well characterized, its 
genetic basis can be deduced through the analysis of the defective protein. Other 
examples of this approach include the identification of the genes underlying 
hemophilia A (Gitschier et al. 1984) and Aspartylglukosaminuria (Ikonen et al. 
1991). 
 
Another way of deciphering the molecular background of a disease is to utilize the 
information available from existing animal models, for example transgenic mice, 
whose phenotype resemble the clinical picture of the disease, and for which the 
genetic defect behind the phenotype is known. An excellent example of this strategy 
is the identification of a juvenile form of the sensory- and motor neuropathy 
Charcot-Marie-Tooth disease (CMT4J), in which the disease gene was first mapped 
in the pale tremor mutant mouse, and the sequencing of the homologous gene in 
human patients resulted in identification of disease mutations (Chow et al. 2007). 
Sometimes an educated guess can be made about the causative gene, as 
demonstrated by the example of RAPADILINO syndrome, in which the underlying 
genetic defect was identified by selection of a candidate gene. Mutations in 
RECQL4 were known to cause two syndromes, whose clinical picture was very 
similar to RAPADILINO. Based on this observation, the RECQL4 gene was also 
sequenced in patients with RAPADILINO, and causative mutations were found 
(Siitonen et al. 2003). 
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2.3.2 Genetic resources 
Genetics provides an excellent tool for tackling the molecular background of 
diseases. The field of genetics has undergone major advancements during the recent 
years and continues to develop at an astonishing pace. The Human Genome Project 
(HGP) was formally initiated in 1990, two of its main objectives being to determine 
the sequence of the three billion chemical base pairs that make up human DNA and 
to identify all of the genes contained within human DNA. The approach was to do 
this by sequencing the complete genome of one individual. In 2001, the working 
draft of the human genome was published simultaneously by the public International 
Human Genome Sequencing Consortium (Lander et al. 2001) and the private 
company Celera Genomics (Venter et al. 2001), and an essentially complete version 
of the sequence was published a few years later (International Human Genome 
Sequencing Consortium 2004).  
 
The HGP was followed by the HapMap project, an international effort to catalogue 
common variation in the human genome between different populations (The 
International HapMap Consortium 2005). Currently a large amount of effort is put 
into sequencing the whole genomes or exomes (the RNA-coding regions of a 
genome) of individuals, the 1000 genomes project (www.1000genomes.org) and the 
UK10k project (www.uk10k.org) being amongst the most extensive of these 
undertakings. The HGP, the HapMap project, and the current sequencing enterprises 
already have, and will also continue to yield an enormous amount of data, which is 
freely accessible to anyone through public databases. This public data of common 
genetic variation in humans is useful, for example, when searching for mutations 
related to disease: comparing patient sequences against it helps filter out the 
common genetic polymorphisms that are not disease-related. The field of medical 
genetics has been quick and efficient in exploiting this data with increasingly rapid 
identification of genes underlying Mendelian traits; the Online Mendelian 
Inheritance in Man (OMIM) database currently lists 2930 entries of phenotypes for 
which the molecular basis is known (www.ncbi.nlm.nih.gov/Omim). 
2.3.3 Positional cloning 
The process of identifying disease genes based on their physical position within the 
genome is referred to as positional cloning (Collins 1992, Collins 1995). This 
approach involves the mapping of the disease locus by genomewide genotyping of 
multiallelic markers followed by linkage analysis. Linkage describes the situation 
when two genetic loci or alleles are inherited together, i.e. they are linked. The aim 
of a linkage study in disease genetics is to map a disease locus by identifying a 
genetic marker that segregates with the disease phenotype in a family or multiple 
families. Linkage is calculated by statistical methods that are based on the testing of 
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probabilities, and depending on the data available, different methods can be utilized, 
including singlepoint, multipoint, parametric or non-parametric analysis. 
Microsatellites are commonly used genetic markers in linkage studies since they are 
highly variable between individuals, thus being very informative. A linkage study 
can only be performed if DNA samples are available from an adequate amount of 
families with a given phenotype. Linkage disequilibrium (LD) refers to a situation in 
which some combinations of alleles or genetic markers (haplotypes) occur more 
frequently in a population than would be expected.  
 
Linkage and LD studies have led to the identification of numerous diseases of the 
FDH. The successful utilization of LD in FDH studies is based on the theory that in 
any given disease, most of the patients share a single founder mutation inherited 
from a common ancestor, and this mutation cosegregates with a shared ancestral 
haplotype. The haplotype, which is derived from an ancestral chromosome, has been 
restricted over time by recombinations during meioses, and thus the genomic 
position of the disease-causing mutation can be fine-mapped by monitoring for 
shared haplotypes in multiple affected families. (Peltonen et al. 1999) 
2.3.4 Homozygosity mapping 
Homozygosity (or autozygosity) mapping is a useful strategy for identifying disease 
loci in consanguineous families suffering from a recessive disease (Lander and 
Botstein 1987). In a child born from a consanguineous marriage, the marker alleles 
of the region surrounding the disease locus are often homozygous, or identical by 
descent (IBD), over a distance of several centiMorgans (cM). It has been estimated 
that approximately 6% of the genome of a child of first cousins is homozygous by 
descent, but comparing regions of IBD between affected and unaffected children of 
the same family can help to pinpoint the most likely disease locus. (Lander and 
Botstein 1987) 
 
Homozygosity mapping has also been successfully used in disease gene 
identification in an isolated population, where consanguinity dates back several 
generations. The critical chromosomal region of the disease locus was defined by 
comparing shared regions of homozygosity between patients from several different 
families. (Tallila et al. 2008) 
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2.3.5 Other genomic methods 
The current advancement in genomic analysis techniques has brought power and 
resolution to the study of the genetic background of disorders. Copy number 
variation (CNV) in particular has been in focus, and current analysis methods allow 
for the detection of CNVs as small as a few hundred base pairs in size (Conrad et al. 
2010). CNVs have been implicated in numerous disorders, including Williams-
Beuren syndrome, Charcot-Marie-Tooth type 1 disease, and Neurofibromatosis type 
1 (Stankiewicz and Lupski 2010).  
 
Exome sequencing has proven its power in the discovery of disease genes; the cause 
for Miller syndrome, a rare Mendelian disorder, was identified by massively parallel 
sequencing of the exomes of four individuals in three different families, combined 
with filtering to exclude benign and unrelated variants (Ng et al. 2010).  
 
Expression array technology enables the study of transcription profiles of different 
cells and tissues, allowing the simultaneous examination of the expression of 
multiple genes and gene networks. Comparisons can be made between the gene 
expression profiles of cases and controls. Computer programs that process 
expression array data based on Gene Ontology (Carbon et al. 2009), a controlled 
vocabulary of terms describing the attributes of genes and gene products, help in 
classifying differentially expressed genes into groups based on, for example, their 
localization or function in the cell, or involvement in a known biochemical pathway. 
This automated grouping of individual genes allows for single molecular events to 
be perceived in a broader context, and helps in pointing out biological pathways and 
processes that are represented by the differentially expressed genes. 
 
RNA-seq, or whole transcriptome shotgun sequencing, is a novel method for 
assaying the mRNA content of a sample, and was developed as an alternative 
method to gene expression arrays (Wang et al. 2009). ChIP-Seq, or chromatin 
immunoprecipitation coupled with massively parallel DNA sequencing, allows 
genome-wide examination of DNA-protein interactions. It can be used to determine 
how chromatin-associated proteins such as transcription factors, polymerases, 
transcriptional machinery, structural proteins, protein modifications, and DNA 
modifications influence the phenotype of an individual. ChIP-Seq can be employed 
in the study of epigenetic chromatin modifications. (Park 2009) 
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2.3.6 Mutations 
The DNA molecule is susceptible to mutations. Types of mutations include point 
mutations, insertions, deletions, duplications, inversions, and translocations. A point 
mutation within the coding region of a gene may be silent, which means that it does 
not affect the polypeptide encoded by the gene, or a missense mutation, which 
changes an amino acid within the polypeptide, or a nonsense mutation, which leads 
to an early stop codon, thus resulting either in a truncated polypeptide, or 
degradation of the mRNA via nonsense-mediated decay and complete loss of protein 
expression. Insertions and deletions within the coding region of the gene may cause 
a shift in the reading frame of the gene or result in aberrant splicing. Intronic 
mutations may also alter splicing by either creating a novel splice site or abolishing 
an excisting one. Mutations can also affect regulatory elements of genes, such as 
transcription factor binding sites, or small noncoding RNAs, such as microRNAs 
(miRNAs). Larger chromosomal rearrengements and copy number variations (CNVs) 
may affect one or multiple genes. 
 
Epigenetic modifications of DNA also contribute to human phenotypes. Imprinting, 
a phenomenon where the expression of certain genes depends on their parental 
origin, is perhaps the most well known example of this. For example, a deletion in 
chromosome 15q can result in either Angelman syndrome or Prader-Willi syndrome, 
depending on the parental origin of the disease chromosome. 
 
A large amount of common variation exists between individuals, but sometimes 
mutations in DNA can be harmful. In medical genetics, distinguishing between 
harmful mutations and common variation is not always straightforward. A recent 
large scale resequencing study shows that, on average, each person carries 
approximately 250 to 300 loss-of-function variants in annotated genes and 50 to 100 
variants previously implicated in inherited disorders (Altshuler et al. 2010). Yet 
most of us are in good health. Although current advances in DNA sequencing 
technologies mean that sequencing itself is no longer neither time consuming nor 
expensive, the storing and analysis of entire human genome sequences, and 
especially the interpretation of these massive amounts of sequence data have 
become increasingly challenging. Careful clinical evaluation of patient samples and 
the use of appropriate control samples, meticulous statistical and bioinformatical 
analysis, as well as functional validation of disease-associated mutations using cell 
models or model organisms are needed in order to establish whether a mutation has 
biological relevance in terms of disease, and should be considered for use in 
diagnostic testing or the development of drugs and therapies. 
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2.4 Human fetal development 
The development of a human fetus is a complex process guided by both genes and 
the environment. The formation of a complete organism from a single cell can be 
divided in three consecutive stages called blastogenesis, organogenesis, and 
fetogenesis. Blastogenesis takes place during the first four weeks of development 
and its completion is marked by the closure of the neural tube, followed by 
organogenesis that lasts until nine weeks of gestation. Fetogenesis lasts from 
gestational week nine until birth. By this time, the main organs have formed and the 
fetus continues to grow in size. The formation of organs starts at an early stage, but 
different organs require different amounts of time to complete their development. 
The heart is formed at six weeks of gestation, the face and limbs at eight weeks. The 
eyes start to form during the seventh week of gestation, on the sides of the head, and 
by the ninth week of gestation, they are situated in the front of the face. The 
structural development of the brain continues until 28 weeks. Human development 
requires the precise functioning and coordination of many complex pathways and 
signaling cascades. Inductive signals between tissues are critical in regulating the 
development of different organs. (Sariola, et al. 2003, Carlson. 2004) 
 
Blastogenesis begins with fertilization, a process where two cells, the sperm and the 
egg, fuse together to form the zygote. This is followed by cleavage, during which 
the zygote undergoes mitotic cell divisions and forms into a blastocyst, while 
simultaneously migrating from the oviduct into the uterus. Once it has reached the 
uterus, the blastocyst invaginates into the uterine endometrium and anchors itself 
into the uterine wall in a process called implantation. Once in place, the trophoblast 
cells of the blastocyst begin dialogue with the uterine wall initiating the formation of 
the placenta. Gastrulation, the formation of three germ layers of the embryo, takes 
place approximately fourteen days after fertilization. These germ layers are the 
ectoderm, mesoderm, and endoderm. The cells of the ectoderm, the outer layer of 
the embryo, give rise to the surface layer of the skin (epidermis), as well as the brain 
and the nervous system. The endoderm, which is the innermost layer of the embryo, 
generates the lining of the digestive tube and its associated organs, including the 
lungs. The mesoderm, which lies between the ectoderm and the endoderm, gives rise 
to the blood, heart, kidneys, gonads, bones, muscles, and connective tissues. Some 
of the cells of the mesoderm also extend outwards from the embryo. These cells will 
generate the blood vessels of the umbilical cord that connects the embryo to the 
placenta. Once the three germ layers are established, their cells interact with one 
another and rearrange themselves into tissues and organs in a process called 
organogenesis. The beginning of organogenesis is marked by the formation of the 
neural tube, which will become the brain and the spinal cord. (Gilbert. 2010) 
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An important aspect of studying human fetal development is understanding the 
process of differentiation. During human development a single cell, the fertilized 
egg, divides and gives rise to hundreds of different cell types. Skin cells, muscle 
cells, different types of neuronal cells, along with many others, are formed in this 
process. However, almost every cell of the body contains the same set of genes, so a 
part of understanding development is determining how the same set of genetic 
instructions can produce different types of cells. (Gilbert. 2010) This dilemma is 
mirrored in the study of genetic disease, where often, a defect in an ubiquitously 
expressed protein results in a tissue-specific phenotype, or a single common 
mutation is found in patients with a diverse array of clinical symptoms. 
 
The differentiated cells divide, migrate, aggregate, and die, and tissues fold and 
separate. During organogenesis, certain cells undergo long migrations from their 
place of origin to their final location. For example, the cells that form the 
craniofacial structures migrate from the neural crest, a strip of cells between the 
newly formed neural tube and the skin of the back. Organs are formed and arranged 
in a particular way in relation to each other. This formation of tissues and organs, 
and the sculpting of the general shape of a human being is called morphogenesis. 
The regulation of cell growth and cell division, as well as controlled cell death 
(apoptosis) are also essential processes in human development. For example, the 
sculpting of the limbs and formation of the digits involves programmed cell death. 
Errors in cell proliferation and apoptosis are seen in cancer, which is why many of 
the molecules that are important in development are also relevant to cancer research. 
(Gilbert. 2010) 
 
 
2.4.1 Neuronal development 
The development of the central nervous system take place in consecutive stages that 
include the induction of neuronal tissue and patterning, the establishment of 
neuroblasts and their migration, the differentiation of neuronal cell types, axonal 
guidance, the establishment of synaptic connections, the regulation of cell number 
by apoptosis, and the arrangement of synaptic connections (Sariola, et al. 2003). The 
detailed molecular basis of vertebrate motor neuron development described below is 
largely based on experiments on chick embryos (Gallus gallus). 
 
The development of the central nervous system starts during the embryonic stage 
when a group of ectodermal cells are induced by the notochord, an event called 
primary induction. Induced neuroepithelial cells form a thickened neural plate, 
which subsequently folds into the neural groove, and finally closes to form the 
neural tube (Sadler 2005). Distinct neuronal subtypes are generated in characteristic 
order along the dorsoventral axis of the developing neural tube (Jessell 2000). The 
2 – Review of the literature 
 
THL  – Research 55/2011 44 Molecular background of three lethal fetal syndromes 
 
differentiation of neuronal cells in the developing neural tube is tightly regulated by 
the expression of specific homeodomain proteins. TGF-β proteins, originating from 
the dorsal ectoderm, influence the dorsal patterning of the neural tube (Lee and 
Jessell 1999), while Sonic hedgehog (Shh) protein generated by the notochord and 
the floor plate of the ventral neural tube controls ventral patterning (Briscoe and 
Ericson 2001). Different types of neurons are generated from distinct progenitor 
domains in the ventral neural tube. Shh acts as a graded signal inducing these 
neuronal subtypes at different concentration threshold and regulates the expression 
profiles of transcription factors Nkx2.2, Olig2, Nkx6.1, Nkx6.2, Dbx1, Dbx2; Irx3, 
Pax6, and Pax7. Each progenitor domain expresses a specific combination of these 
transcription factors (Figure 5) (Briscoe and Ericson 2001, Ribes and Briscoe 2009, 
Dessaud et al. 2010). The expression of target genes in response to graded Shh 
signalling in the ventral neural tube is mediated by the transcriptional effector 
proteins Gli1, Gli2, and Gli3 (Jacob and Briscoe 2003, Vokes et al. 2007). As 
progenitor cells in the progenitor domains proliferate and exit the cell cycle, they 
express a combination of LIM homeodomain (LIM-HD) and bHLH transcription 
factors that define neuronal cell type identity. The anterior horn motor neurons arise 
from the pMN progenitor domain (Figure 5). The motor neuron progenitor domain 
expresses the LIM-HD factors Lhx3/Lhx4 and Isl1 that activate motor neuron 
specific transcription (Ericson et al. 1992, Sharma et al. 1998, Thaler et al. 2002), as 
well as the bHLH transcription factors Ngn2 and NeuroM (Ma et al. 1996, Roztocil 
et al. 1997, Scardigli et al. 2001). The coexpression of these molecules marks a 
transient period in development during which motor neurons begin to acquire 
general neuronal properties, become postmitotic, and differentiate. The Hb9 protein 
actively suppresses interneuron differentiation programs in developing motor 
neurons thus promoting motor neuron development and axon pathfinding (Arber et 
al. 1999, Thaler et al. 1999) . 
 
Motor neurons in the spinal cord are organized into longitudinally aligned columns, 
each composed of neurons that innervate the same target tissue. This spatial 
organization of motor columns serves as basis for classifying spinal motor neuron 
subtypes (Bonanomi and Pfaff 2010). In the hindbrain, motor neurons arise from 
two progenitor domains that are adjacent to each other, but genetically distinct; 
hypoglossal motor neurons arise from Pax6 progenitor cells and coexpress Isl1, Isl2, 
and transiently, Lhx3 and Gsh4, whilst vagal motor neurons derive from Nkx2.2 
progenitor cells and coexpress Isl1 and Gsh4, but not Isl2 or Lhx3 (Ericson et al. 
1997). Outgrowth of nerve cell axons is led by the growth cone located on the tip of 
the axon. During axonal migration, the microspikes of the growth cone enable 
motility and provide structural support, and also sense the environment and send 
back signals to the cell soma. Two families of transcription factors have been 
implicated in the control of motor axon navigation: the 12 member LIM-HD class of 
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transcription factors and the 39 member HOX family of HD proteins (Tsuchida et al. 
1994, Dasen et al. 2005).  
 
 
 
 
 
 
 
 
 
 
Figure 5. Generation of neuronal diversity in the ventral neural tube in response to graded Shh 
signalling. N notochord, F floor plate. V0 neurons, V1 neurons, V2 neurons, motor neurons (MN) and 
V3 neurons are generated at distinct progenitor domains (p3-p0) in the ventral spinal cord. Shh acts as a 
graded signal inducing these neuronal subtypes at different concentration threshold and regulates the 
expression profiles of transcription factors Nkx2.2, Olig2, Nkx6.1, Nkx6.2, Dbx1, Dbx2; Irx3, Pax6, and 
Pax7. Each progenitor domain expresses a unique combination of transcription factors. Modified from 
(Briscoe and Ericson 2001, Ribes and Briscoe 2009, Dessaud et al. 2010) 
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The axons of neurons are insulated by a sheath of myelin provided by glial cells that 
wrap around the axon. In the central nervous system, axon insulation is provided by 
glial cells called oligodendrocytes, while in the peripheral nervous system, 
myelination is accomplished by glial cells called Schwann cells. The myelin sheath 
is essential for normal functioning of neurons. Motoneurons release neuregulin 1 to 
promote Schwann cell survival and development (Trachtenberg and Thompson 1996, 
Fischbach and Rosen 1997, Hayworth et al. 2006). 
 
Naturally occurring cell death of neurons during development is regulated by the 
synthesis and secretion of neurotrophins by neuronal target tissues (Oppenheim 
1991). The prototypic neurotrophin is nerve growth factor (NGF), discovered in the 
1950s as a soluble peptide (Cohen et al. 1954), promoting the survival of and neurite 
outgrowth from sympathetic ganglia (Levi-Montalcini 1987). Approximately 50% 
of motor neurons undergo programmed cell death during the course of development. 
Since the discovery of NGF, the investigation of this process of physiological motor 
neuron cell death has resulted in the identification of several neurotrophic factors 
that influence motor neuron survival, including neurotrophins (Bdnf, Nt-3, Nt4/5), 
Cntf/Lif family proteins (Cntf, Lif, Ct-1, Clc), Hepatocyte growth factor/scatter 
factor (Hgf/Sf), Insulin-like growth factors (Igf-1, Igf-2), and Glial-derived 
neurotrophic factor and related factors (Gdnf, Ntf, Persephin, Artemin) (Sendtner et 
al. 2000). 
 
The establishment of synaptic connections between muscle tissue and the motor 
neurons that innervate it requires reciprocal signalling. A neuromuscular junction 
(NMJ) is a specific type of synapse that forms between motor neurons and skeletal 
muscle fibers. Multiple neurons compete to form a single neuromuscular junction, 
but only one neuron that is able to successfully respond to signalling from its target 
tissue will survive and establish a connection. (Witzemann 2006) In vertebrates, the 
neuromuscular junction utilizes Acetylcholine (ACh) as a neurotransmitter. 
Acetylcholine receptors (AChRs) in the muscle fibers are initially present in a broad, 
poorly defined area in the middle of the muscle fiber, but innervations results in the 
clustering of AChRs in the synaptic region, and the disappearance of primitive 
clusters in non-synaptic areas (Wu 2010). Muscle fibers express neurotrophin 3 to 
modulate the number of Schwann cells in developing NMJs (Hess et al. 2007). Mice 
lacking Neuregulin 1 or its receptors Erbb2 or Erbb3 lack Schwann cells 
(Riethmacher and Sonnenberg-Riethmacher 1997, Morris et al. 1999, Woldeyesus et 
al. 1999, Lin et al. 2000, Wolpowitz et al. 2000), and the synapses formed between 
their motor neurons and muscle fibers fail to be maintained, suggesting an important 
role for Schwann cells in the formation and maintenance of neuromuscular junctions. 
(Wu 2010) 
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2.4.2 Development of craniofacial structures 
The structures of the face and head are mostly derived from the cells of the cranial 
neural crest. The cranial neural crest cells migrate into the pharyngeal arches and the 
frontonasal process, and once they have reached their final destination, differentiate 
to form different craniofacial structures. The migration of these cells is driven by an 
underlying segmentation process of the hindbrain. The hindbrain is segmented into 
compartments called rhombomeres, numbered from rhombomere one to 
rhombomere eight (r1-r8). Neural crest cells from the midbrain and rhombomeres 
one and two migrate to the first pharyngeal arch and form the jawbones, as well as 
the incus and malleus bones of the middle ear, and also differentiate into nerve cells 
that innervate the teeth and the jaw. They also form the frontonasal process, which 
forms the forehead, the middle of the nose, and the primary palate. Neural crest cells 
from r4 and r6-r8 contribute to the formation of neck cartilage, the thymus, 
parathyroid and thyroid glands, and assist in the construction of the aorta and the 
pulmonary artery (Bockman and Kirby 1984, Serbedzija et al. 1992, Creuzet et al. 
2005). The neural crest cells from rhombomeres three and five do not migrate, but 
undergo apoptosis (Ellies et al. 2002). The skull bones are derived both from the 
neural crest and the head mesoderm. Studies in transgenic mice suggest that in 
vertebrates, the bones of the front of the face are generally derived from the neural 
crest, while the back of the skull originates from a combination of neural crest-
derived and mesodermal bones. 
 
The formation of facial features is influenced by various paracrine factors. Wnt 
signalling induces the protrusion of the frontonasal and maxillary prominences, 
giving shape to the face (Brugmann et al. 2006).  Fibroblast growth factor (FGF) 
signalling induces neural crest formation (Baker and Bronner-Fraser 1997, 
Villanueva et al. 2002, Monsoro-Burq et al. 2003, Monsoro-Burq et al. 2005) and 
promotes the formation of the chondrocyte (i.e. cartilage forming) lineage in the 
cranial neural crest (Sarkar et al. 2001, Monsoro-Burq et al. 2005). Fibroblast 
growth factors (FGFs) and their receptors (FGFRs) are broadly expressed in the 
developing face (Bachler and Neubüser 2001). FGFs are involved in the outgrowth 
of the facial primordial, craniofacial skeletogenesis, sculpting of the palate, 
development of teeth and salivary glands, as well as the development of facial 
muscles (Nie et al. 2006a). The role of FGFs and FGFRs in craniofacial 
morphogenesis has been widely studied in mouse models. For example, studies on 
mice indicate that Fgfr1 influences localized signalling in the pharyngeal ectoderm 
and the development of the second branchial arch (Trokovic et al. 2003, Trokovic et 
al. 2005). 
 
Another important group of signalling molecules involved in the development of the 
cranial neural crest and facial primordial are the Bone morphogenic proteins (BMPs). 
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BMPs work in tandem with FGF and Wnt signalling pathways in the formation of 
the neural crest and sculpting of the face. BMPs are also involved in craniofacial 
skeletogenesis and muscle development, and are crucial for the closure of the facial 
midline. Disturbances in this process result in orofacial clefts such as cleft lip and 
cleft palate. (Nie et al. 2006b) The critical role of BMPs in facial midline fusion is 
indicated by studies on mice (Dudas et al. 2004, Liu et al. 2005). Sonic hedgehog 
(Shh) signalling is also essential for normal craniofacial morphogenesis. Mutations 
in the human SHH gene cause holoprocencephaly, a developmental defect of the 
forebrain and midface (Roessler et al. 1996). 
 
2.4.3 Development of the epidermis and cutaneous structures 
The embryonic ectoderm differentiates to form the nervous system and the 
epidermis of the skin. Cutaneous structures such as teeth, sweat glands, mammary 
glands, hair, and nails are also derived from the ectoderm. The skin is the largest 
organ in the human body. Its outermost layer is the epidermis, a stratified epithelium 
that consists mostly of proliferating basal and differentiated suprabasal keratinocytes. 
The epidermis is divided into layers, which are, from the outside inwards: 
 
1. cornified layer (stratum corneum) 
2. translucent layer (stratum lucidum) 
3. granular layer (stratum granulosum) 
4. spinous layer (stratum spinosum) 
5. basal layer (stratum basale) 
 
Normally, the stratified epithelium is maintained by continuous cell proliferation 
within the basal layer, from where cells are pushed outwards. Once the cells reach 
the stratum corneum, they lose their nuclei, fuse to form squamous sheets, and are 
eventually shed. This process is called the terminal differentiation program, and it is 
defined by growth arrest, expression of structural proteins, such as loricrin and 
filaggrin, and cell death through enucleation (Fuchs and Byrne 1994). In normal skin, 
the rate of proliferation is equal to the rate of cell loss. The entire epidermis is 
replaced by new cell growth in approximately 48 days (Iizuka 1994).  
 
The epidermis develops from the surface ectoderm, which initially consists of a 
multipotent single-layer epithelium. Upon receiving the appropriate developmental 
cues, these epithelial cells begin to stratify, proliferate, and finally undergo terminal 
differentiation to produce the morphologically distinct layers of the epidermis (Mack 
et al. 2005). The epidermal developmental program that is first seen in the fetus is 
maintained also in the epidermis of the adult organism, where stem cells of the basal 
layer continuously produce new skin cells.  
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The transcription factor p63 is a leading candidate for the molecular switch required 
to initiate stratification of the embryonic single-layered epithelium. It is highly 
expressed in the epidermal basal layer, and studies in knockout mice suggest that it 
may also be required to sustain the basal stem cell population (Yang et al. 1998). 
Notch signalling is implicated in the basal cells’ withdrawal from the cell cycle and 
commitment to terminal differentiation. Conditional elimination of Notch1 from the 
basal layer of newborn epidermis results in epidermal hyperproliferation, indicating 
a failure of cells to undergo growth arrest (Rangarajan et al. 2001). In mice, Notch1 
is expressed as early as E15.5 in the developing epidermis (Okuyama et al. 2004), 
indicating that Notch signaling may be important for the initial growth arrest signals 
that allow the cells to enter a differentiation program. NF-κB transcription factors 
play an important role in growth arrest and morphogenesis in the developing and 
renewing epidermis (Mack et al. 2005). CHUK (IKKα), a component of the NF-κB 
pathway, acts in the nucleus to induce keratinocyte differentiation (Sil et al. 2004), 
and also functions in epidermal development independently of NF-κB (Hu et al. 
2001). 
 
Various Bone morphogenic protein (BMP) ligands and receptors are expressed in 
different compartments of the developing epidermis. BMP-6 transcript is expressed 
in the suprabasal layers of the epidermis of mouse embryos starting from E15.5, 
BMP-7 is seen in the basal layer during the later stages of embryonic development, 
BMPR-IA is expressed in the basal layer of murine epidermis at E16.5, and BMPR-
IB expression is restricted to the suprabasal keratinocytes (Wall et al. 1993, 
Takahashi 1996, Botchkarev et al. 1999). 
 
HOX genes (HOXA4, HOXA5, HOXA7, HOXB4, and HOXC4) are expressed in 
human fetal epidermis beginning as early as 10 weeks of gestational age (Stelnicki 
et al. 1998), suggesting a function early in epidermal development as transcriptional 
activators of cellular proliferation (Mack et al. 2005). 
 
Cutaneous structures such as hair, sweat glands, mammary glands, and teeth also 
develop from the embryonic ectoderm. EDA, EDAR, and EDARADD control the 
development of cutaneous structures via NF-κB signalling (Kere et al. 1996, 
Ferguson et al. 1997, Srivastava et al. 1997, Headon and Overbeek 1999, Monreal et 
al. 1999, Headon et al. 2001).  
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2.4.4 Errors in development 
A famous quote by Professor Veronica Van Heyningen states: “The amazing thing 
about development is not that it sometimes goes wrong, but that it ever succeeds”. It 
is estimated that more pregnancies are miscarried than are actually carried to term 
(Rai and Regan 2006). The number is difficult to estimate since often the 
miscarriage occurs even before the woman is aware of her pregnancy. Most 
miscarriages are sporadic and non-recurrent, and are often caused by chromosomal 
abnormalities of the fetus (Dhont 2003). The most common chromosomal 
abnormalities seen in miscarriages are trisomy of the chromosome 16, followed by 
trisomy 21 and trisomy 22 (Stephenson and Kutteh 2007). Other commonly seen 
chromosomal abnormalities associated with miscarriage include polyploidy, 
monosomy X, and unbalanced translocation (Kalousek et al. 1993, Stephenson et al. 
2002). Trisomy 21, found in Down’s syndrome, and monosomy X, found in Turner 
syndrome, as well as unbalanced translocations, are not invariably fatal, though. 
Chromosomal abnormalities may arise de novo, or they can be due to parental 
germline mosaicism, or a balanced chromosomal translocation in the parental 
genome that results in the formation of gametes with an abnormal chromosomal 
content. 
 
Approximately two percent of human infants are born with an observable 
anatomical abnormality, a birth defect. Birth defects can be caused by genetic events, 
such as mutations or an abnormal amount of chromosomes, or environmental factors 
(teratogens) such as drugs and chemicals (e.g. alcohol, heroin, retinoic acid, 
antibiotes, thalidomide, and warfarin), ionizing radiation, infectious micro-
organisms (e.g. Cytomegalovirus, Herpes simples, Parvovirus, Rubella, and 
toxoplasmosis), or metabolic conditions in the mother (e.g. autoimmune disease, 
Diabetes, malnutrition, and Phenylketonuria). The developing fetus is most 
susceptible to teratogens between three to eight weeks of gestation, a time when 
organs are forming. However, the nervous system remains susceptible to damage 
throughout the pregnancy. (Gilbert. 2010) 
 
The formation of the human neural tube begins early during the third week of 
gestation. The nervous system continues to grow and mature throughout embryonic 
and fetal development, and connections between neurons integrate the parts of the 
body and the brain. Failures in this process result in neural tube birth defects such as 
anencephaly (anterior part of the neural tube fails to close) and spina bifida 
(posterior part of the neural tube fails to close). Folic acid, or vitamin B9, is known 
to be an important molecule in the closure of the neural tube, and obtaining 
sufficient amounts of this vitamin is essential for pregnant women. (Gilbert. 2010) 
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2.5 Animal models 
Various different animal models are used in biological and biomedical research. The 
budding yeast (Saccharomyces cerevisiae) and fission yeast (Schizosaccharomyces 
pombe) are employed in the study of basic molecular and cellular mechanisms of the 
eukaryotic cell. The roundworm (Caenorhabditis elegans) has been particularly 
useful in studying cell fate and apoptosis during development. The Africal clawed 
frog (Xenopus laevis) has been an important model in developmental biology 
because of its large and easily manipulable embryo, but it has a tetraploid genome, 
which makes it a less desirable candidate for genetic studies. A related frog species, 
the Xenopus tropicalis, which has a simpler genome, is now widely used. The 
chicken (Gallus gallus) has also been widely used in developmental research, 
particularly the study of limb formation. 
 
The mouse (Mus musculus) is the most popular mammalian model used in biological 
and biomedical research. Gene targeting in mouse embryonic stem cells is a 
technique of engineering specifically tailored mutant mice that enables the 
generation of gene-specific knockouts or knock-ins, as well as tissue-specific 
expression of mutant genes (Capecchi 2005). The Mouse Genome Database is an 
online resource of mouse genomics, gene expression, and mutant mouse phenotypes 
(Bult et al. 2008). 
 
The zebrafish (Danio rerio) has many qualities that make it a practical and widely 
used model organism in the study of development and disease. Zebrafish embryos 
develop externally and can be made optically transparent by inhibiting pigment 
formation, which enables direct monitoring of their development in vivo, and the use 
of fluorescent reporters and indicators to visualize morphology and physiology of 
specific cell groups of interest (Sager et al. 2010). The fish breed regularly, produce 
large amounts of offspring, and can be housed in large numbers enabling large-scale 
genetic screens (Brockerhoff et al. 1995, Driever et al. 1996, Amsterdam et al. 1999, 
Amsterdam et al. 2004) and chemical screens (Zon and Peterson 2005). The 
zebrafish genome has been duplicated during the course of evolution, which makes 
genetic studies challenging since some, but not all zebrafish genes are present in 
multiple copies (Amores et al. 1998). Genetic manipulation techniques, such as the 
use of morpholino antisense oligonucleotides, can be employed to investigate the 
function of a particular gene during zebrafish development (Eisen and Smith 2008). 
The zebrafish genomic sequence and other resources are available online 
(www.zfin.org) (Sprague et al. 2006). 
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2.5.1 The Zebrafish as a model of neurodegeneration 
The zebrafish central nervous system (CNS) is considerably smaller than the human 
CNS, and has some structural differences as well. However, many areas of the 
zebrafish CNS that are relevant in terms of disease are structurally similar to those in 
humans. For example, both the zebrafish and human cerebellum have molecular, 
Purkinje cell and granule cell layers. The cell types present in the each of these 
layers are alike in zebrafish and humans; they show similar inputs and synaptic 
connections, and express similar genes and specialized markers (Bae et al. 2009). 
One difference is that the cell bodies of output projection neurons in the zebrafish 
cerebellum (eurydendroid cells) are located in the cortex rather than the deep nuclei 
found in humans. However, other regions of the zebrafish CNS, such as the medulla, 
hypothalamus, optic tracts and tectum, olfactory system, spinal cord, and cranial 
nerves show easily recognizable structural homology to their human counterparts. 
(Sager et al. 2010) 
 
In order to investigate whether the zebrafish could be used as a model organism for 
studying the pathogenesis of ALS, a study used mRNA microinjection to cause 
transient over-expression of mutant SOD1 in developing zebrafish embryos 
(Lemmens et al. 2007). The microinjected animals showed normal morphology and 
normal development of Mauthner neurons, Rohan-Beard sensory neurons and lateral 
line sensory neurons. However, the motor neurons in the microinjected animals 
displayed abnormal branching and shortened axon length (Lemmens et al. 2007). 
Knocking down the survival motor neuron (Smn) gene, which is mutated in human 
patients with Spinal Muscular Atrophy (SMA), causes defects in motor axon 
outgrowth and pathfinding in zebrafish (McWhorter et al. 2003).  Thus the zebrafish 
can be considered a good model organism for the study of human motor neuron 
disease, where often the ubiquitous expression of a mutant protein results in a motor 
neuron-specific neuropathology. 
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3 Aims of the study 
The aims of this study were the following: 
 
1. To identify the molecular defect behind LCCS1 
 
2. To identify the molecular defect behind LAAHD 
 
3. To describe in detail a familial case of fetal encasement malformation 
 
4. To investigate the molecular background of the fetal encasement 
malformation
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4 Subjects, materials and  
 methods 
4.1 Subjects and samples 
Samples for the study were available from 29 LCCS1 families, with 52 affected 
fetuses and 73 healthy individuals (including parents and healthy siblings). There 
were ten LAAHD families with a total of thirteen affected individuals. DNA was 
extracted from blood, frozen and paraffin-embedded tissue, cultured cells, and 
chorionic villus samples. RNA was extracted from frozen tissue and cultured cells. 
A fibroblast cell line was available from two LCCS1 fetuses and from one fetus of 
North American origin, whose phenotype was similar to LCCS1. In addition, we 
analyzed samples from ten foreign families with suspected cases of LCCS1 or 
LAAHD.  
 
For the fetal encasement malformation study, samples were available from one 
family with two affected fetuses and their parents. DNA was extracted from blood 
and cultured cells, and RNA from cultured cells. Fibroblast cell lines and tissue 
samples were available from both affected fetuses. 
 
In addition, DNA was available from 200 Finnish control samples. 
 
Fetal DNA, tissue samples and fibroblast cell lines were available from healthy 
fetuses aborted for non-medical reasons. 
4.1.1 Ethical aspects 
Informed written consent was obtained from the parents of the families participating 
in the study. The studies were approved by the Ethical Committees of the Joint 
Authority for the Hospital District of Helsinki and Uusimaa. 
 
4.2 Methods 
4.2.1 Methods used in original publications 
The methods used in this study are listed in Table 5 and described in detail in the 
original publications. 
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Table 5. The original publications in which the methods are used are indicated with Roman numerals. 
Method  Publication 
Bioinformatic analyses I, II
Cell culture I, II
Cell transfections I
Direct sequencing I, II
DNA extraction I, II
Genealogy II
Genotyping I
Haplotype analyses I
Immunofluorescence microscopy I
Immunofluorescence staining I
Microarray analysis II
Polymerase chain reaction (PCR) I, II
Protein immunoprecipitation II
Reverse transcription polymerase chain reaction (RT‐PCR) I, II
RNA extraction I, II
RNA in situ hybridization I
Western Blot II
 
 
4.2.2 Materials and methods used in unpublished studies 
 
Mutant gle1-/- zebrafish embryos 
Two strains of gle1 +/- zebrafish were available for studies at the Wellcome Trust 
Sanger Institute, Cambridge, UK. One of these strains containing a transgenic 
insertion, which disrupts the gle1 gene, was previously identified in a scan for 
developmental genes in zebrafish (Amsterdam et al. 2004). The other strain, which 
carries a truncating point mutation in gle1, was identified in a genetic screen at the 
Vertebrate development and genetics research group at the Wellcome Trust Sanger 
Institute (Dr. Derek Stemple and Dr. Richard White, personal communication). Wild 
type AB zebrafish were available as controls. Fish strains were maintained in the 
Wellcome Trust Sanger Research Support Facility (RSF) in accordance with UK 
laws and regulations concerning experiments with animals, and in compliance with 
the ethical guidelines issued by the Wellcome Trust Sanger Institute. 
 
4 – Subjects, materials and methods 
 
THL  – Research 55/2011 56 Molecular background of three lethal fetal syndromes 
 
Acridine orange (AO) staining of gle1-/- zebrafish embryos 
Adult zebrafish were set up to mate in breeding pairs, and fertilized embryos were 
collected from the bottom of the breeding tanks. Embryos were reared in egg water 
(60 μg/ml sea salt, 0.0002% methylene blue) containing 0.2 mM 1-phenyl 2-thiourea 
(PTU). PTU was used to inhibit pigment formation in embryos in order to obtain 
better images. Mutant gle1-/- embryos could be distinguished from siblings by 
viewing them under the microscope due to the obvious phenotype of markedly 
reduced movement compared to the wild type siblings, a small head, and small eyes. 
Identification was verified by genotyping mutant and wild type embryos, and the 
results were consistent with the visual identification. Images of embryos were taken 
at two days post fertilization (2dpf). Prior to imaging, the egg water containing the 
embryos was supplemented with Acridine orange (AO) to a final concentration of 
5μg/ml, and allowed to stand for 30 minutes. The egg water was then changed a few 
times to wash off excess AO, and embryos were mounted in methyl cellulose for 
live imaging on the Leica TCS SP5 II broadband confocal microcope. 
 
Whole mount Poly-A in situ hybridization of zebrafish embryos 
Localization of polyadenylated RNA was assayed by in situ hybridization.  A 
digoxygenin-tailed poly(dT)50 oligonucleotide probe was used to detect 
polyadenylated messenger RNA (Forrester et al. 1992, De Bruyn Kops and Guthrie 
2001), and digoxygenin-labelled RNA probes synthezised in the antisense- and 
sense direction from a plasmid containing a fragment of the dbx1a gene (Gribble et 
al. 2009), whose expression pattern in the zebrafish embryo is distinct and well 
studied, were used as positive and negative controls for the hybridization method. 
Whole mount in situ hybridization was carried out as described previously (Thisse 
and Thisse 2008). After probe hybridization, staining was done with anti-
digoxygenin conjugated with horseradish peroxidase (anti-DIG-POD) and Tyramide 
Signal Amplification TSA Cy3 substrate (Perkin Elmer). Embryos were also stained 
with DAPI to visualize the nuclei within the individual cells. Images were taken 
with the Leica TCS SP5 II broadband confocal microscope. 
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5 Results and discussion 
5.1 Identification of the LCCS1 disease gene (I) 
 
Prior to this thesis work, the LCCS1 locus had been mapped to chromosome 9q34 
by linkage (Mäkelä-Bengs et al. 1998). The critical chromosomal region for the 
disease gene was restricted between markers D9S1827 and D9S752 based on 
recombinations in a shared ancestral haplotype observed in LCCS1 families (Figure 
6). Some candidate genes had also been sequenced (Table 6) (Pakkasjärvi 2005b). 
This sequencing work had been done simultaneously with the progress of the 
Human Genome Project at a time during which a conclusive genetic map of the 
region was not yet available. Although the HGP had officially been completed, the 
genetic map of the LCCS1 region in chromosome 9q34 was still updated on a 
regular basis even during the course of this thesis work, with discovery of new 
transcripts in the region, and changes is the number of coding exons within existing 
transcripts, which made it essential, but also challenging to keep track of what had 
already been sequenced. Gene nomenclature also changed during the course of the 
work (Table 6).  
 
 
 
 
Figure 6. Recombinations in the shared ancestral haplotype restrict the critical chromosomal region of 
the LCCS1 locus. 
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Table 6. Candidate genes sequenced prior to this study. The left-hand column lists the gene names that 
were valid in the year 2004, in which this thesis work was started. The right-hand column lists the same 
genes by their current official names as stated in the National Center for Biotechnology Information 
(NCBI) database (www.ncbi.nlm.nih.gov) 
2004     2010
Gene  Full name Gene Full name
LCN2  lipocalin 2  LCN2  lipocalin 2 
STXBP1  syntaxin binding protein 1  STXBP1  syntaxin binding protein 1 
ZNF‐X  zinc finger X transcription factor  ZBTB43  zinc finger and BTB domain containing 
43 
DNM‐1  dynamin 1  DNM1  dynamin 1 
KIAA1069  novel gene    not found in NCBI database 
CCBL  cysteine conjugate‐beta lyase  CCBL1  cysteine conjugate‐beta lyase, 
cytoplasmic 
SPTAN  brain spectrin alpha / fodrin  SPTAN1  spectrin, alpha, non‐erythrocytic 1 
(alpha‐fodrin) 
ZYG  ZYG‐11 homolog B  ZER1  zer‐1 homolog (C. elegans) 
ENDOG  endonuclease  G  ENDOG  endonuclease G 
VSN  novel gene    not found in NCBI database 
SH3GLB2  endophilin B2  SH3GLB2 SH3‐domain GRB2‐like endophilin B2 
CEECAM1  cerebral endothelial cell adhesion 
molecule 1 
CERCAM  cerebral endothelial cell adhesion 
molecule 
DOLPP1  dolichyl pyrophosphate 
phosphatase 1 
DOLPP1  dolichyl pyrophosphate phosphatase 
1 
CRAT  carnitine acetyltransferase  CRAT  carnitine O‐acetyltransferase 
LRRC8  leucine‐rich repeat‐containing 
protein 8 
LRRC8A  leucine rich repeat containing 8 
family, member A 
PHYHD1  phytaonyl‐CoA dioxygenase 
domain containing 1 
PHYHD1  phytanoyl‐CoA dioxygenase domain 
containing 1 
IER5L  immediate early response gene 5L  IER5L  immediate early response 5‐like 
PPP2R4  phosphotyrosyl phosphatase 
activator 2A 
PPP2R4  protein phosphatase 2A activator, 
regulatory subunit 4 
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The size of the LCCS1 region in chromosome 9q34 between markers D9S1827 and 
D9S752 is 1 Mb, and it contains 30 protein-coding genes (UCSC Human Genome 
Browser, February 2009 Assembly) (genome.ucsc.edu) (Figure 7 and Table 7). 
Searching for a causative mutation by sequencing regional candidate genes of three 
affected LCCS1 individuals and two controls revealed that the region was very 
homogeneous. While searching for the causative mutation, we also searched for 
polymorphisms that would segregate with the LCCS1 disease haplotype, and could 
potentially be used to further restrict the critical chromosomal region, but discovered 
only SNPs that were present in both patients and controls, and thus most likely 
represent ancient polymorphisms that were introduced to the Finnish population 
before the appearance of the LCCS1 disease mutation. 
 
Eventually, we found one previously unidentified SNP in the 3’UTR (untranslated 
region) of the SLC27A4 gene, which seemed to segregate with the disease. All 
affected LCCS1 individuals in 28 families were homozygous, and their parents 
heterozygous for the G allele of this SNP. In the one remaining LCCS1 family, the 
fetus was heterozygous for the G allele, and the disease associated ancestral 
haplotype was observed in only one parent, who was also heterozygous for the G 
allele. Of 200 healthy controls, 1% were heterozygous for the disease associated G 
allele, but none were homozygous. A theoretical estimate of the carrier frequency of 
the LCCS1 disease mutation, which can be calculated using the Hardy-Weinberg 
equation and the observed incidence of LCCS1 in the Finnish population (1:25,250), 
is 1,3%, which is relatively close to the observed 1% in our 200 controls. The 
location of this SNP in the 3’UTR of the gene did not make it the most likely 
candidate for a pathogenic mutation, even though the polymorphism segregated with 
the LCCS1 phenotype. However, a mutation in the non-coding region of a gene 
might still affect the expression of the transcript, for example by creating a micro-
RNA binding site, and therefore, at this stage, the SNP could not be completely 
ruled out as a possible disease-causing mutation. 
 
Because of the phenotypic similarity between LCCS1 and LAAHD, we next 
investigated the LCCS1 disease region and the newly identified SLC27A4 
polymorphism in LAAHD families. Comprehensive genotyping of all the LAAHD 
families was not possible due to the poor quality of some of the DNA samples, 
which were mostly extracted from paraffin blocks. To investigate the SLC27A4 
polymorphism in cases with LAAHD we designed a special PCR with a very short 
amplicon, which enabled the analysis of this SNP also in low quality LAAHD DNA 
samples extracted from paraffin-embedded tissue. Interestingly, almost all of the 
LAAHD fetuses were also heterozygous for this SNP, except for a pair of identical 
twins, whose phenotype was somewhat intermediate between LCCS1 and LAAHD, 
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and who were heterozygous for the shared ancestral LCCS1 haplotype, but 
homozygous for the wild type A allele of the SNP. This suggested that the 
polymorphism was most likely not pathogenic, but rather in almost complete LD 
with the true disease-causing mutation. Given the low incidence of this SNP in the 
general population and its frequent occurrence in LAAHD families, we concluded 
that LCCS1 and LAAHD might be allelic, and thus the recombination observed in 
one LAAHD family enabled us to further restrict the critical chromosomal region to 
800,000 bp, reducing the amount of regional candidate genes to 24 (Figure 7).  
 
We screened all of the regional candidate genes for possible disease causing 
mutations by direct sequencing and found potential mutations in only one of them, 
GLE1. In 28 out of 29 LCCS1 families, affected fetuses were homozygous and 
parents heterozygous for a point mutation in intron 3 of the GLE1 gene, ten base 
pairs upstream of exon 4 (c.433-10A>G). In one LCCS1 family, where the shared 
ancestral haplotype was inherited only from one parent, the fetus was a compound 
heterozygote for the c.433-10A>G mutation and a missense mutation in exon 12 
(c.1706G>A). 
 
 
 
 
Figure 7. The critical chromosomal region for the LCCS1 locus. A polymorphism in the SLC27A4 gene 
restricted the critical chromosomal region to 800,000 bp, and mutations in LCCS1 patients were found 
in the GLE1 gene. 
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 Table 7. List of protein coding genes located in the LCCS1 locus between markers D921827 and 
D9S752 according to UCSC Human Genome Browser February 2009 assembly. Genes sequenced from 
genomic DNA prior to this study are indicated in grey.  These genes were resequenced from cDNA during 
this study. 
Gene  Full name 
DNM1  dynamin 1 
GOLGA2  golgin A2 
c9orf119  chromosome 9 open reading frame 119 
TRUB2  TruB pseudouridine (psi) synthase homolog 2 (E. coli) 
COQ4  coenzyme Q4 homolog (S. cerevisiae) 
SLC27A4  solute carrier family 27 (fatty acid transporter), member 4 
URM1  ubiquitin related modifier 1 
CERCAM  cerebral endothelial cell adhesion molecule 
ODF2  outer dense fiber of sperm tails 2 
GLE1  GLE1 RNA export mediator homolog (yeast) 
SPTAN1  spectrin, alpha, non‐erythrocytic 1 (alpha‐fodrin) 
WDR34  WD repeat domain 34 
SET  SET nuclear oncogene 
PKN3  protein kinase N3 
ZDHHC12  zinc finger, DHHC‐type containing 12 
ZER1  zer‐1 homolog (C. elegans) 
TBC1D13  TBC1 domain family, member 13 
ENDOG  endonuclease G 
c9orf114  chromosome 9 open reading frame 114 
CCBL1  cysteine conjugate‐beta lyase, cytoplasmic 
LRRC8  leucine rich repeat containing 8 family, member A 
PHYHD1  phytanoyl‐CoA dioxygenase domain containing 1 
DOLK  dolichol kinase 
NUP188  nucleoporin 188kDa 
SH3GLB2  SH3‐domain GRB2‐like endophilin B2 
FAM73B  family with sequence similarity 73, member B 
DOLPP1  dolichyl pyrophosphate phosphatase 1 
CRAT  carnitine O‐acetyltransferase 
PPP2R4  protein phosphatase 2A activator, regulatory subunit 4 
IER5L  immediate early response 5‐like 
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5.1.1 Screening LAAHD families for mutations in GLE1 
We sequenced the GLE1 gene from twelve LAAHD fetuses in nine families. Six of 
these fetuses were compound heterozygous for the LCCS1 FinMajor mutation (c.433-
10A>G) and a missense mutation in exon 13 (c.1849G>A), and the remaining six 
were compound heterozygous for the LCCS1 FinMajor mutation (c.433-10A>G) 
and a missense mutation in exon 16 (c.2051T>C). We also analyzed the DNA of one 
patient who had congenital arthrogryposis, but survived for two months after birth. 
An initial diagnose of spinal muscular atrophy (SMA type I or type 0) was made in 
this case, but no SMN gene deletions were found. The autopsy showed neurogenic 
muscle atrophy and loss of anterior horn cells of the spinal cord. This case was also 
compound heterozygous for the LCCS1 FinMajor mutation (c.433-10A>G) and the 
mutation in exon 16 (c.2051T>C), and thus the diagnosis was amended as LAAHD 
(albeit with unusually prolonged survival). Thus the mutation analysis of the 
LAAHD samples confirmed that LCCS1 and LAAHD are allelic disorders, and that 
the compound heterozygous mutations in GLE1 seem to result in a milder phenotype 
than the homozygous LCCS1 FinMajor mutation. So far, we have not observed the 
amino acid substitutions of exon 12, exon 13, or exon 16 in a homozygous state in 
any individuals. It would be extremely interesting to see what kind of phenotype 
such a mutation would cause. 
 
After the publication of Original publication I, LAAHD was assigned with a MIM 
number (MIM 611890). 
5.1.2 The effect of the mutations on the GLE1 protein 
Sequencing of cDNA of the LCCS1 fetuses revealed that the intronic (c.433-
10A>G) mutation creates an illegitimate splice acceptor site and results in the 
insertion of nine extra nucleotides into GLE1 mRNA. Since exon three ends in a full 
codon, the aberrant splicing does not disrupt the reading frame, but results in the 
insertion three extra amino acids (proline, phenylalanine, and glutamine) into the 
GLE1 protein. Figure 2 in Original Publication I illustrates the structure of the GLE1 
gene and the GLE1 protein in detail. The GLE1 protein contains multiple domains, 
including the putative coiled coil domain. Coiled coils are secondary, alpha-helical 
protein structures that contain a characteristic heptad repeat motif (abcdefg)n, and 
can be reliably predicted from sequence (McDonnell et al. 2006). We used the 
Paircoil2 algorithm (groups.csail.mit.edu/cb/paircoil2/) to compare predicted coiled 
coil structures of the mutant and wild type GLE1 polypeptides, and observed that the 
mutant protein is less likely to form a coiled coil structure than the wild type protein 
(Original Publication I, Supplementary Table 4). One residue that could have a 
significant impact on secondary protein structure of the mutant protein is proline, 
whose cyclic structure represents exceptional conformational rigidity compared to 
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other amino acids. When proline occurs in the middle of alpha helixes, it usually 
disrupts the helical structure. 
 
For evaluating the missense mutations in exon 12, exon 13, and exon 16, we used 
the PolyPhen bioinformatics tool (genetics.bwh.harvard.edu/pph/) (Ramensky et al. 
2002), which predicts the possible effects of the amino acid substitution on the 
protein by the basis of protein sequence annotation, multiple sequence alignments, 
and structural information. PolyPhen classifies mutations as benign (most likely 
lacking any phenotypic effect), possibly damaging (supposed to affect protein 
function or structure), or probably damaging (with high confidence supposed to 
affect protein function or structure). Table 8 lists the mutations observed in LCCS1 
and LAAHD patients and their predicted effects on the GLE1 protein. 
 
 
Table 8. Mutations found in LCCS1 and LAAHD patients and their predicted effects on the GLE1 
protein. A novel mutation described in section 5.1.3. is also included in the table. 
Mutation  Predicted effect on 
polypeptide 
Exon  Intron  Predicted 
consequences 
c.433‐10A>G  p.T144_E145insPFQ    3  Destroys coiled coil 
domain (Paircoil2) 
c.1706G>A  p.R569H  12    Probably damaging 
(PolyPhen) 
c.1849G>A  p.V617M  13    Benign (PolyPhen) 
c.2051T>C 
 
 
c.581+1_581+2delGT 
p.I684T 
 
 
 
16 
 
 
 
 
 
4 
Possibly damaging 
(PolyPhen) 
 
missplicing 
 
5.1.3 Screening additional patients for mutations in GLE1 (unpublished 
data) 
We screened ten foreign families with suspected LCCS1 or LAAHD diagnosis from 
various different ethnic backgrounds for mutations in GLE1, but found no 
pathogenic mutations in them. In addition, we sequenced a fetus of Finnish origin 
with suspected LCCS1, whose sample we received after the Original publication 1, 
and observed that the sample was a compound heterozygote for the mutation in 
GLE1 exon 13 and a novel mutation that abolishes an existing splice donor site in 
the exon 4/intron 4 junction of GLE1. The novel mutation is a deletion of two 
nucleotides (c.581+1_581+2delGT). Analysis of patient cDNA by agarose gel 
electrophoresis confirmed that this mutation results in aberrant splicing of GLE1 
mRNA.  
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5.2 GLE1 function 
 
The GLE1 gene has two splice variants that encode two different forms of GLE1 
protein, GLE1A and GLE1B. GLE1A is encoded by the first 14 exons of the GLE1 
gene, whereas GLE1B is encoded by all 16 exons. The two proteins are identical 
except for their C-terminal regions (Kendirgi et al. 2003). Since some patients with 
LAAHD are compound heterozygotes for the LCCS1 FinMajor mutation and an 
amino acid substitution in exon 16 of GLE1, while others are compound 
heterozygous for the LCCS1 FinMajor mutation and an amino acid substitution in 
exon 13, and there are no obvious phenotypic differences between these two types of 
LAAHD patients, it is reasonable to assume that the full length isoform of GLE1 
(GLE1B) is more relevant in terms of the disease mechanism.  
 
Both GLE1 isoforms localize diffusely in the cytoplasm, but GLE1B is also 
localized in the nuclear envelope and the nuclear pore complex (Rayala et al. 2004). 
GLE1B forms a heterotrimeric complex with nucleoporins NUP155 and NUPL2 
(alias CG1) in vitro and is required for the export of heat shock protein 70 (HSP70) 
mRNA from the nucleus to the cytoplasm in budding yeast as well as in human cells 
(Kendirgi et al. 2003, Kendirgi et al. 2005). The highly conserved C-terminal 
NUPL2-binding domain of GLE1B is required for the localization of GLE1B to the 
nuclear pore complex (Rayala et al. 2004). A small organic molecule, inositol 
hexakisphosphate (IP6) binds directly to the yeast homologue of GLE1, and together 
they stimulate the ATPase activity of DEAD-box protein DBP5 for mRNA export 
from the nucleus to the cytoplasm. Importantly, although GLE1 alone can enhance 
the ATPase activity of DBP5, the ATPase activity is maximally stimulated by the 
presence of both GLE1 and IP6 (Tran et al. 2007). The C-terminal domain of GLE1 
is also required for interactions with DBP5 (Alcazar-Roman et al. 2006, Weirich et 
al. 2006).  
 
Studies in the budding yeast have shown that in addition to mRNA export, Gle1 also 
functions in translation initiation and translation termination. Studies suggest that 
Gle1 operates together with inositol hexakisphosphate and Dbp5 in translation 
termination, whereas IP6 and Dbp5 are not required for the translation initiation 
function of Gle1. Gle1 also has a conserved physical association with the eukaryotic 
translation initiation factor eIF3 and the translation termination factor Sup45. 
(Bolger et al. 2008) 
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5.2.1 Overexpression of mutant and wild type GLE1 in HeLa-cells 
We cloned the wild type and LCCS1 FinMajor mutant GLE1 cDNA into expression 
vectors containing a gene for Green fluorescent protein (GFP) and overexpressed the 
GLE1-GFP constructs in HeLa cells. There was no difference between the 
intracellular localization of the mutant and wild type GFP fusion proteins (Original 
publication I, Supplementary figure 3). The localization for both proteins was 
similar to that observed in previous studies of wild type GLE1 overexpression in 
HeLa cells (Kendirgi et al. 2003). The overexpression of a fusion protein, however, 
does not necessarily reflect the endogenous cellular localization of the protein of 
interest. At the time of these overexpression studies, there were no GLE1 antibodies 
available. Now that GLE1 antibodies have become commercially available, it would 
be interesting to stain LCCS1 patient cells and control cells for endogenous GLE1 
and see, whether there is a difference in the expression or localization of endogenous 
GLE1 protein between LCCS1 patients and controls. 
5.2.2 In situ hybridization 
We performed RNA in situ hybridization to investigate the expression of wild type 
Gle1 during mouse embryonic development. RNA in situ hybridization on sagittal 
sections of E11 and E13 (E = embryonic day) mouse embryos showed low, 
ubiquitous expression of Gle1. In addition to this, expression was also detected in 
somites, from which skeletal muscle and bone tissue differentiate, as well as in lung 
epithelial cells, intestinal wall, esophagus, and brain, specifically the developing 
choroid plexus. Marked expression was seen in the ventral cell population of the 
neural tube in the E11 embryo. (Original publication I, Supplementary figure 2) 
 
As mentioned in section 2.4.1, the differentiation of neuronal cells in the developing 
neural tube is tightly regulated by the expression of specific homeodomain proteins. 
There is a gradient of Sonic hedgehog (Shh) protein that regulates the expression of 
transcription factors, such as Nkx2.2 and Pax6. Shh concentration is highest in the 
ventral cell population of the neural tube that is closest to the notochord, and 
becomes more diluted once distance from the notochord increases. (Briscoe and 
Ericson 2001) 
 
In our previous studies of global transcript profiles of the spinal cords of LCCS1 
fetuses we did not observe any significant change in the steady state transcript level 
of GLE1, but we detected marginal down-regulation of NKX2.2 and up-regulation of 
PAX6 (Pakkasjärvi et al. 2007). 
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5.2.3 LCCS1, LCCS, and LCCS3 disease genes are linked by a common 
pathway 
Inositol hexakisphosphate (IP6) is a member of the inositol polyphosphates, a group 
of small molecules that participate in various functions in the cell (see section 
2.3.6.). The LCCS2 and LCCS3 disease genes belong to the biosynthetic pathway 
that is responsible for the production of inositol hexakisphosphate (Figure 8). 
Studies in the budding yeast have shown that yeast strains lacking enzymes in this 
pathway have reduced interactions between Gle1 and Dbp5 (Weirich et al. 2006). 
Thus it is possible that there is a common disease mechanism in these three lethal 
motoneuron diseases, and that this disease mechanism is related to the functions of 
GLE1. 
 
 
 
 
Figure 8. Studies in the budding yeast (Saccaromyces cerevisiae) suggest that the causative genes for 
LCCS1, LCCS2, and LCCS3 are all members of the same pathway. 
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5.2.4 Posttranscriptional RNA processing  
The eukaryotic messenger RNA (mRNA) is transcribed in the nucleus, processed by 
the splicing machinery, and actively transported to the cytoplasm, where it is 
translated into protein, and eventually degraded by exonucleases. Throughout this 
process, mRNAs are accompanied by a host of associated factors, some of which are 
stably bound while others are subject to dynamic exchange (Moore 2005). The 
budding yeast is estimated to express almost 600 proteins that have the capacity to 
bind RNA (Costanzo et al. 2001). In humans this number is thought to be 
considerably larger, since just a single type of RNA binding domain, the RNA 
recognition motif (RRM), is present in nearly 500 human genes (Maris et al. 2005), 
and in addition to this, there are at least five more types of common RNA binding 
domains found in human genes (Messias and Sattler 2004, Stefl et al. 2005). 
 
The mRNA, associated proteins, and small noncoding RNAs, make up the 
messenger ribonucleoprotein particle (mRNP). Some mRNAs travel as individual 
mRNPs, while others cluster and migrate in larger ribonucleoprotein particle (RNP) 
structures. In neurons, such particles can contain roughly 30 mRNAs and have 
diameters up to 1 µm (St. Johnston 2005). Some mRNP components, such as 
nucleocytoplasmic shuttling hnRNPs (heterogeneous nuclear RNPs), are first 
assembled in the nucleus, simultaneously with transcription and pre-mRNA 
processing, and accompany the mature mRNA into the cytoplasm. The mRNP helps 
to regulate the spatial and temporal expression of mRNA within the cell (Martin and 
Ephrussi 2009). The individual mRNP components allow mRNAs to interface with 
the intracellular machineries that regulate their subcellular localization, translation, 
and decay (Moore 2005). The assembly of mRNPs, their export into the cytoplasm 
through the NPC, and mRNP localization to specific compartments of the cell thus 
represent a central step in the regulation of gene expression. 
 
The mRNPs are actively exported from the nucleus to the cytoplasm through the 
nuclear pore complex. Export of mRNPs through the NPC is coincident with altered 
protein-protein and protein-RNA interactions in the mRNP complex. The DEAD 
box protein DBP5, GLE1, and inositol hexakisphosphate (IP6) are essential mRNA 
export factors at the nuclear pore required for mRNP remodeling and the 
nucleosytoplasmic transport of mRNA (Tran et al. 2007). Once they have reached 
the cytoplasm, individual mRNP particles can either passively diffuse until they are 
trapped by an anchor protein, or be actively transported into subcellular localizations 
along the cytoskeleton by myosins, dyneins, or kinesins (St. Johnston 2005). Once 
the mRNAs enter the cytoplasm, not all are immediately translated into protein. 
Some mRNAs remain actively repressed until they arrive at a specific location in the 
cell where protein synthesis can take place.  
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Eukaryotic translation takes place in four distinct stages: initiation, elongation, 
termination, and recycling (Kapp and Lorsch 2004). Eukaryotic initiation factors 
(eIFs) that stimulate ribosome loading are key molecules in translation initiation, 
which involves the assembly of translation-competent ribosomes on mRNA. One of 
these initiation factors, the eIF3, also regulates dissociation and recycling of the 
ribosome after translation termination (Pisarev et al. 2007). The termination of 
translation and the release of the completed polypeptide, also a critical step in gene 
expression, is regulated by proteins called eukaryotic release factors (eRFs) (Kapp 
and Lorsch 2004). 
 
Localized mRNA translation is particularly important to large cells such as neurons. 
During brain development, local translation of mRNAs in axonal growth cones 
allows neurons to respond to local environmental cues as the distal axonal processes 
navigate toward their synaptic partners, and in the mature brain, localized mRNA 
synthesis enables synaptic plasticity (Martin and Ephrussi 2009). 
 
5.2.5 RNA processing and motor neuron disease 
The discovery of defective GLE1 behind the molecular pathogenesis of LCCS1 and 
LAAHD, as well as other recent advances in motor neuron disease genetics, 
highlight the importance of RNA processing in the pathogenesis of motor neuron 
disease.  
 
Spinal Muscular Atrophy (SMA) is caused by mutations in the SMN1 gene, which 
encodes the Survival of motor neurons (SMN) protein. SMN is found in both the 
nucleus and the cytoplasm of the cell. In the nucleus, SMN localizes in specks called 
“gems” that overlap or are closely associated with Cajal bodies, structures that 
contain high levels of factors involved in transcription and processing of many types 
of nuclear RNA (Liu et al. 1997). In addition, SMN is found in granules in the axons 
of neurons, where it is rapidly transported bi-directionally (Zhang et al. 2003, Zhang 
et al. 2006). SMN is also enriched at the growth cone of motor neurons (Rossoll et 
al. 2003). Studies suggest that SMN is involved in diverse aspects of RNA 
metabolism, including pre-RNA splicing, transcription, and metabolism of 
ribosomal RNAs. (Sumner 2007) 
 
Spinal Muscular Atrophy with Respiratory Distress (DSMA1, MIM 604320) is 
another severe early onset motor neuron disease, and is caused by mutations in the 
IGHMBP2 gene. The protein encoded by this gene has a helicase domain, and it co-
localizes with the RNA-processing machinery in both the cytoplasm and the nucleus 
(Miao et al. 2000). 
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The rare childhood or adolescent-onset autosomal dominant form of Amyotrophic 
Lateral Sclerosis ALS4 (MIM 602433) is caused by mutations in SETX, encoding 
senataxin, a protein containing a C-terminal motif typical for DNA/RNA helicases. 
The SETX gene shares homology with the IGHMPB2 gene and also with RENT1, 
both encoding proteins with a role in RNA processing. Mutations in the TARDBP 
and FUS genes have also been found in ALS patients. The TARDBP gene encodes 
for the TDP43 protein, which contains two RNA recognition motifs, and a C-
terminal hnRNP-interacting domain. TDP43 shuttles between the nucleus and the 
cytoplasm, and has a role in RNA processing as well as the regulation of alternative 
splicing (Buratti and Baralle 2010). FUS, like TDP43, also binds RNA, shuttles 
between the nucleus and the cytoplasm, and has multiple functions involving mRNA 
processing (Buratti and Baralle 2010). These characteristics of TDP43 and FUS are 
strikingly similar with each other, as well as with the attributes and cellular 
functions of GLE1. These discoveries have shifted the focus of cellular studies of 
ALS pathogenesis from the extensively studied superoxide dismutase SOD1 enzyme 
to RNA processing events, possibly leading to novel therapeutic approaches in 
treating ALS.  
 
5.2.6 gle1 -/- zebrafish (unpublished data) 
Mating of heterozygous gle1+/- zebrafish produced offspring of which approximately 
25% had an abnormal phenotype, which was clearly distinguishable from siblings at 
two days post fertilization. Genotyping confirmed that these phenotypically 
abnormal fish were gle1-/- . Both the transgenic mutant and the point mutant fish 
have identical phenotypes. The mutant fish have a small head and small eyes. At two 
days post fertilization the mutant fish display cell death in their central nervous 
system, most clearly visible in the optic tectum, which can be seen when looking 
through the microscope as a dark mass of cells. Staining by Acridine orange (AO) 
confirmed that 2dpf gle1-/- embryos have significantly more dying cells in their brain 
and spinal cord than their wild type siblings. Also, the gut and the eyes of gle1-/- 
embryos have marked cell death. (Figure 9)  
 
There is also marked cell death in the hatching gland cells of the gle1-/- embryos at 
two days post fertilization. The hatching gland is a set of cells located on the 
pericardial membrane of the zebrafish embryo. It appears at the segmentation stage 
of the embryo (at 14-16 hours post fertilization) and disappears during the pec-fin 
developmental stage, which starts at 60 hours post fertilization. The hatching gland 
cells secrete enzymes that degrade the chorion and allow the embryo to hatch. Once 
the embryo has hatched these cells undergo apoptosis. The difference in the amount 
of apoptotic hatching gland cells between the mutant and wild type fish could be a 
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timing issue, which could be further looked into by monitoring the development and 
apoptosis of hatching gland cells in mutant and wild type fish over time. 
 
By five days post fertilization the gle1-/- embryos have severe oedema of the rostral 
region, a slow heart beat, and significantly reduced movement compared to their 
wild type siblings. The localization of polyadenylated RNA within the cells of both 
mutant and wild type zebrafish embryos was assayed by RNA in situ hybridization 
using a probe that binds the polyA-tails of mRNA molecules. DAPI staining was 
used to visualize the nuclei. As seen in Figure 10, the mRNA within the cells of 
gle1-/- embryos is mostly retained inside or around the nuclei, whereas in wild type 
embryos, a more diffuse localization throughout the cell is seen. 
 
The retention of mRNA in the cell nucleus would seem like such a grave defect, that 
one would presume it would be lethal at a very early stage. The images showing a 
difference in the intracellular localization of mRNA in zebrafish cells are from 
epithelial cells, suggesting the mRNA retention in the nucleus is not limited to cells 
of the nervous system. The zebrafish embryo expresses maternal mRNA in the 
beginning of its development, which could explain why the gle1-/- zebrafish are able 
to survive for so long. The DAPI stain used to visualize the nucleus stains DNA. It 
would be useful to also stain the nuclear membrane to assess whether the mRNA is 
actually completely retained inside the nucleus, or partially located around the outer 
perimeter of the nucleus as well, in which case translation of proteins would be 
possible. This could also explain why cell death is seen in the nervous system; nerve 
cells are among the largest cells in vertebrates, and localized translation of mRNAs 
far away from the nucleus, at the rim of the cell (e.g. the synapse) is critical for their 
functioning. The retention of mRNA in the proximity of the nucleus would perhaps 
not be so detrimental to a smaller cell, but large, specialized cells such as neurons, 
which depend on effective transport of mRNA species to various compartments of 
the cell, would be vulnerable to such a defect. 
 
The cell death in the central nervous system seems to be more extensive in gle1-/- 
zebrafish than the cell death observed in the human LCCS1 fetuses. This could be 
due to the differences between the human and zebrafish nervous systems, or 
difference in the function of gle1 in these two organisms, but also the nature of the 
LCCS1 disease mutation could explain the difference. The LCCS1 FinMajor mutation 
is an in-frame insertion that is predicted to result in three extra amino acids in the 
GLE1 protein. Since there were no GLE1 antibodies available at the time when cell 
studies could have been conducted with LCCS1 patient cells, we have not assayed 
GLE1 protein expression in LCCS1 patients. Rather than completely lacking the 
GLE1 protein, it is possible that patients express a mutant protein, which might still 
be able to perform the functions of the normal GLE1 protein in the cell to some 
extent, in which case the complete knockout of gle1 in zebrafish would not be a 
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good strategy for studying the LCCS1 disease mechanism. The use of gle1-/- 
zebrafish, however, would allow an experiment in which a rescue of the gle1-/- 
phenotype could be attempted by injection of wild type gle1 mRNA into fertilized 
gle1-/- zebrafish eggs. A mutant mRNA containing the LCCS1 FinMajor mutation 
could also be injected into another group of fertilized eggs. This experiment would 
provide a more accurate assessment of the effects of the LCCS1 FinMajor mutation in 
zebrafish and determine whether the zebrafish would be a good organism for 
studying the LCCS1 disease mechanism.  
 
 
 
 
Figure 9. Acridine orange staining of wild type (left) and gle1-/- (right) zebrafish. The gle1-/- zebrafish 
have marked cell death in their central nervous system, the gut, and the eyes. They also exhibit increased 
cell death in the hatching gland cells. 
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Figure 10. Staining of polyadenylated mRNA in gle1-/- (top) and wild type (bottom) zebrafish at 2dpf 
shows that in mutant cells, the mRNA is mostly retained inside or around the nucleus, whereas in wild 
type cells, the distribution of mRNA is more even throughout the cell. 
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5.3 Fetal encasement malformation (II) 
 
As a research group that specializes in deciphering the molecular background of 
fetal malformation syndromes, we had established close collaboration with the 
clinicians of the Women’s Hospital in Helsinki. The case of one particular family 
with a unique, very severe fetal malformation recurring in two consecutive 
pregnancies was brought to our attention. We took up the challenge of investigating 
this unusual case. 
5.3.1 Clinical description of the cases 
The family described in this study consists of healthy parents of Finnish origin who, 
to their knowledge, are not consanguineous. They had five pregnancies. The first 
pregnancy ended in a spontaneous miscarriage at the end of the first trimester; the 
fetus was not available for study. In the two consecutive pregnancies, multiple 
malformations of the fetuses were seen. The fourth and fifth pregnancies resulted in 
the birth of normal infants. 
 
An ultrasonogram examination carried out during the 14th and 13th weeks of the 
second and third pregnancies, respectively, displayed identical, abnormal findings. 
In both cases, an abnormal cyst in the cranial part of the fetus, malformations of the 
craniofacial area, and an omphalocele were seen. The limbs were immotile and 
visible only as small buds. Based on these ultrasonogram findings, the pregnancies 
were terminated at the 15th and 14th weeks of gestation, respectively. The autopsy 
revealed that the extremities of the fetuses were actually encased by the abnormal, 
membrane-like, transparent skin. Both fetuses had a bifid orifice in the middle of the 
face, and small eyes situated on either side of this formation. The mouth was just a 
depression covered with skin. In addition to these findings, the first fetus had a 
defect in the diaphragm, a cardiac defect (Fallot tetralogy), a horseshoe kidney, 
underdeveloped skull bones, and a lobulation defect in both lungs with four lobes in 
the right lung and three lobes in the left lung. The second fetus also had a lobulation 
defect with three lung lobes in each lung, but the other inner organs appeared normal. 
An X-ray of the first case revealed that the bones of the spine, thorax, lumbar area, 
base of the skull, face, and the extremities existed, but were hypoplastic. There were 
a normal number of vertebrae and ribs, but the spine was scoliotic. Histological 
examination on bone structure revealed a normal growth plate and no features of 
chondrodystrophy (a congenital hamartia of cartilage). There were no specific 
histological changes visible in the internal organs. However, histological 
examination on skin sections of the extremities showed a thin, membrane-like 
epidermis with only two to three cell layers (Original publication II, Figure 2). 
Primitive hair follicles were also found. Within the bony structures of the head, there 
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was an island of squamous epithelium, which probably represents an unopened 
mouth. Both fetuses had a normal, female karyotype (46, XX), which rules out large 
chromosomal rearrengements. Pictures of the affected fetuses can be found in Figure 
1 of Original publication II. 
5.3.2 Genealogical investigations 
The recurrence of this unusual phenotype in one family suggested autosomal 
recessive inheritance, so we undertook genealogical investigations in order to find 
out if the parents were distantly related. We traced ancestors back to 1850 from 
Finnish Population Register Centre and local church registers. For earlier periods, 
we scrutinized microfiche copies of local church records available in the National 
Archives of Finland. Based on this analysis, the parents share a common ancestor; 
they are both the descendants of a couple that lived in Ristijärvi (Figure 11) during 
the 18th century. From the father’s side, this consanguinity dates back nine 
generations, and from the mother’s side, seven generations (Figure 11). This 
consanguinity reflects the typical population substructure of Finland, and supports 
the theory of autosomal recessive inheritance. 
 
 
 
 
Figure 11. Genealogical investigations suggest that the couple share a common ancestor in 18th century 
Ristijärvi (marked in black on the map) 
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5.3.3 Genome-wide gene expression array analysis 
We established genome-wide gene expression arrays from fetal fibroblast cell lines 
of the two cases and three healthy controls aborted for social reasons using the 
Affymetrix platform in order to gain knowledge about the molecular pathways 
behind the encasement malformation. The analysis of expression data produced a list 
of 132 transcripts that were differentially expressed in cases and controls (a list of 
the differentially expressed genes can be found in the Supplementary table 1 of 
Original publication II). 
 
Methods of gene expression array data analysis rely on statistics to point out the 
most significant result. We performed the standard statistical analyses, but in 
addition to this, also looked further into the differentially expressed genes in order to 
gain insights into the biology behind the statistics. Since animal models have 
successfully been utilized in the search for disease causing mutations in humans 
(Chow et al. 2007), we searched the Mouse Genome Database (Bult et al. 2008) for 
murine knockouts of the genes that were downregulated in the affected fetuses. 
 
Interestingly, mice lacking the conserved helix-loop-helix ubiquitous kinase Chuk 
(also known as Ikk1 and Ikkα) bore a striking phenotypic resemblance to our cases 
(for a detailed description of the Chuk -/- mouse phenotype, see section 5.3.6). The 
CHUK transcript was downregulated 8.5-fold in our cases, making it an excellent 
candidate gene for the syndrome. The comparison of human and mouse CHUK 
proteins by Basic Local Alignment Search Tool shows a 95% similarity, which 
suggests this protein has an analogous, conserved function in both species and 
therefore the impairment of human CHUK might result in a phenotype parallel to 
that of the Chuk knockout mouse. It is important to note that the difference in the 
expression of the CHUK transcript between cases and controls was less significant 
than that of many other transcripts, but combining existing biological information 
with the results of the statistical analysis clearly made CHUK the single most 
attractive candidate gene. 
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5.3.4 Analysis of the CHUK gene and CHUK protein 
To search for the causative mutation, we amplified the coding region of CHUK 
(NM_001278) from the cDNA of the cases and two control samples. Sequence 
analysis of CHUK revealed that both affected fetuses were homozygous for a C to T 
substitution (c.1264C>T) in exon 12 of CHUK. This mutation was also observed in 
the genomic DNA of the fetuses. Sequencing of the genomic DNA of both parents 
showed that both of them are heterozygous carriers of this mutation. We then 
screened one hundred ancestrally matched controls for the mutation, and found no 
heterozygote carriers or homozygotes. The CHUK gene consists of 21 exons, and 
encodes a protein of 745 amino acids. The 1264C>T mutation changes the 
glutamine at position 422 to a stop codon (p.Gln422X), which predicts a truncated 
polypeptide of 421 amino acids, assuming that the mutant messenger RNA is not 
degraded (Figure 12). To assay CHUK protein expression, we used 
immunoprecipitation followed by western blot analysis of cell lysates made from 
fibroblasts of the fetal skin. We used an antibody that binds to the N-terminal part of 
CHUK to establish whether affected fetuses express a truncated protein product and 
observed no bands in lanes containing samples derived from the cases, suggesting 
that mutant CHUK RNA is degraded via the nonsense-mediated decay mechanism 
and mutant protein is not expressed. (Original publication II, Figure 3) 
 
 
 
 
 
 
Figure 12. The CHUK gene and the CHUK protein. The mutation in exon 12 and amino acid position 
422 is marked with a star. 
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Nonsense-mediated mRNA decay (NMD) is a pathway that targets mRNAs that 
contain premature termination codons (PTCs) and marks them for degradation 
(Baker and Parker 2004, Holbrook et al. 2004, Maquat 2004, Conti and Izaurralde 
2005, Fasken and Corbett 2005, Lejeune and Maquat 2005, Wilkinson 2005, 
Yamashita et al. 2005, Chang et al. 2007). This pathway is important for the 
maintenance of cellular integrity, since PTC-containing messages would produce 
truncated proteins with potentially deleterious gain-of-function or dominant-
negative activity, if they were allowed to be translated. NMD is a highly conserved 
pathway that exists in all eukaryotes (Culbertson 1999).  
 
The core NMD machinery is made up of three trans-acting factors, called up-
frameshift (UPF) proteins, the UPF1, UPF2, and UPF3 (Leeds et al. 1992, Cui et al. 
1995, Lee and Culbertson 1995). UPF1 is recruited to mRNAs upon recognition of 
stop codons by the translation apparatus (Czaplinski 1998, Kashima et al. 2006). 
The interaction of UPF1 with UPF2 and UPF3 triggers rapid decay of PTC-bearing 
mRNAs. In mammalian cells, UPF2 and UPF3 are part of the exon-junction 
complex (EJC), a large complex of proteins that is deposited on mRNAs at exon-
exon junctions during RNA splicing in the nucleus. The EJC is thought to play an 
important role in distinguishing premature stop codons from legitimate ones and 
thus determining which mRNAs are marked for NMD (Chang et al. 2007). In 
addition, NMD requires factors that regulate UPF1 phosphorylation. SMG-1, SMG-
5, SMG-6, and SMG-7 control the phosphorylation status of UPF1 (Wilkinson 
2003). All four SMGs are required for NMD, since mutations in any one of these 
components inhibits NMD (Chang et al. 2007). 
 
Mammalian NMD seems to occur as a result of PTC recognition during a 
proofreading round of translation, since the substrate for this proofreading round of 
translation has a different mRNP composition than subsequent rounds of translation 
that generate large amounts of protein (Chang et al. 2007). Upon translation 
termination, release factors recruit UPF1 and the UPF1 kinase SMG-1 to form the 
SURF complex, a transient complex that quickly interacts with the EJC through 
UPF2. This SURF-EJC interaction defines the stop codon as premature. Once 
phosphorylated, UPF1 attracts the phosphoserine-binding domain proteins SMG-5, 
SMG-6, and SMG-7 that promote the dephosphorylation of UPF1. SMG-7 is 
thought to be the terminal effector of NMD because it accumulates in P-bodies, 
cytoplasmic sites of mRNA decay. SMG-7 also elicits rapid decay when tethered to 
any position within an mRNA, which is an unique characteristic among NMD 
proteins. Recent studies suggest that mammalian NMD is not a single pathway, but 
has several branches, some of which may use alternative EJCs and others that may 
operate independent of EJCs (Chang et al. 2007). 
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5.3.5 CHUK and NF-κB 
The conserved helix-loop-helix ubiquitous kinase CHUK is also known as IκB 
kinase α (IKKα), and it is a subunit of the multiprotein complex IκB kinase (IKK). 
IKK has two catalytic subunits, CHUK and IKKβ, and a regulatory subunit IKKγ 
(NEMO). In response to proinflammatory stimuli, the IKK complex phosphorylates 
IκB proteins, which in turn lead to IκB degradation. IκB inhibits NF-κB/Rel 
transcription factors by blocking their nuclear localization sequence. When IκB 
function is abolished, NF-κBs translocate to the nucleus, where they regulate target 
genes (Hu et al. 1999). (Figure 13) 
 
CHUK and IKKβ share over 50% amino acid identity, and they both phosphorylate 
IκB proteins at serines, but it has been shown that CHUK is not required for NF-κB 
activation (Hu et al. 2001). Instead, it regulates epidermal development and skeletal 
morphogenesis in an NF-κB independent manner (Hu et al. 1999, Li et al. 1999, 
Takeda et al. 1999, Sil et al. 2004). 
 
 
 
Figure 13. CHUK is part of a multiprotein complex IκB kinase that regulates NF-κB transcription 
factors. 
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5.3.6 Chuk -/- mice 
Mice that are deficient in Chuk (Chuk -/- mice) have been independently generated 
by three different research groups (Hu et al. 1999, Li et al. 1999, Takeda et al. 1999). 
Chuk -/- mice are carried to term, but die shortly after birth. The pups have multiple 
morphogenetic defects. Their skin is unusually shiny, thick, and adhesive, and it 
encases the limbs, which appear externally only as rudimentary protrusions. Limb 
bones, however, are close to normal shape, and of almost normal length, but they are 
tightly folded under the skin. The tail is also rolled up under the skin. The pups have 
a truncated snout and no external ears, and multiple skeletal defects. Mutant fetuses 
also have an omphalocele, and the placentae are severely congested with bulging 
vessels and blood sinuses on the maternal surface and normal fetal surface. 
Histological staining of skin sections of the Chuk -/- mice with hematoxylin and eosin 
shows hyperplasia of the suprabasal layer (stratum spinosum), and lack of the two 
outer layers of the epidermis, stratum granulosum and stratum corneum. The 
increased thickness of the suprabasal layer of the mutant epidermis results from 
hyperproliferation of the keratinocytes and their inability to differentiate (Hu et al. 
1999). In mutant pups, the esophagus, an organ whose inside is also covered in 
keratinocytes, is closed up. No obvious abnormalities of the heart, lungs, liver, 
kidney, spleen, brain, or spinal cord are seen at autopsy. (Hu et al. 1999, Li et al. 
1999, Takeda et al. 1999) 
 
The phenotypic similarity between the Chuk -/- mice and human fetuses lacking 
CHUK is remarkable. Both have limbs that are encased under the skin, but limb 
bones are close to normal shape and length. However, both the Chuk -/- mice and the 
human fetuses have other skeletal defects, including the absence of some of the skull 
bones (Hu et al. 1999). Chuk -/- mice have fused vertebrae, a small thoracic cage, and 
a cleft palate (Hu et al. 1999, Li et al. 1999). This is interesting, since one of the 
genes downregulated in our affected fetuses is the Cleft lip and palate associated 
transmemmbrane protein CLPTM1. A balanced translocation disrupting the 
CLPTM1 gene was discovered in a family with cleft lip and palate, but screening of 
the CLPTM1 gene in other patients with nonsyndromic cleft lip and palate failed to 
identify causative pathogenic mutations (Yoshiura et al. 1998). The human fetuses 
lacking CHUK have a normal number of vertebrae and ribs, but the spine is scoliotic. 
However, craniofacial malformations seem to be more severe in human fetuses than 
in Chuk -/- mice, suggesting that CHUK has a substantial role in human craniofacial 
morphogenesis, although the precise mechanism by which CHUK is involved in the 
development of craniofacial structures still remains to be discovered. The cyst seen 
in the ultrasound examination of the human fetuses could be the esophagus, since in 
the Chuk -/- mice, the esophagus is closed up due to hyperproliferation of 
keratinocytes in the esophageal epithelium. 
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5.3.7 Pathway analysis of the gene expression array data 
To investigate the cellular pathways and processes disturbed by the absence of 
CHUK in our affected fetuses, we analyzed the expression data further using the 
WebGestalt program (Zhang et al. 2005). WebGestalt is a WEB-based GEne SeT 
AnaLysis Toolkit that processes gene lists, and groups differentially expressed genes 
into functional categories. The WebGestalt program recognized 91 of the 132 
transcripts that were differentially expressed in our cases and controls. We grouped 
the differentially expressed genes in three different ways, according to: 
 
1. Biological process  
2. Molecular function 
3. Cellular component 
 
Grouping according to biological process showed that in the affected fetuses, genes 
that regulate ossification, establishment of protein localization, cell motility, 
phosphate transport, and the I-κB kinase/NF-κB cascade were significantly different 
from controls. When differentially expressed transcripts in cases and controls were 
classified by molecular function, genes related to actin filament binding, protein 
phosphatase inhibitor activity and the extracellular matrix stood out. When over-
represented genes were classified according to cellular component, those encoding 
proteins of the extracellular region and matrix (ECM), cytoskeleton, and ER-Golgi 
intermediate compartment were most highly ranked. (Original publication II, 
Supplementary Table 2 and Supplementary Figure 1) 
 
5.3.8 MMP-14 
The extracellular matrix category included a large number of genes downregulated 
in the affected fetuses. One of these genes encodes the matrix metallopeptidase 
(MMP-14), essential for skeletal development (Zhou et al. 2000) and formation of 
blood vessels (Davis et al. 2007). We performed a western blot analysis of the fetal 
fibroblast cell lysates to assay for MMP-14 protein expression and, unexpectedly, 
observed protein expression in the fibroblasts of affected fetuses but not those of 
age-matched controls (data not shown). This could be explained, for example, by a 
negative feedback loop mechanism. Given the complexity of posttranscriptional 
mRNA processing discussed in section 5.2.4, it is known that mRNA levels in the 
cell do not necessarily correspond with protein expression levels (Moore 2005). 
Mice deficient in MMP-14 exhibit impaired endochondral ossification and 
angiogenesis (Zhou et al. 2000). Interestingly, also keratinocyte-specific Chuk 
knockout mice displayed increased vascularization in their paws (Gareus et al. 2007), 
suggesting a link between the Chuk and Mmp14 proteins. 
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5.3.9 CHUK and NF-κB signalling in the development of ectodermally 
derived structures 
Based on phenotypic observations of Chuk -/- mice it was concluded that Chuk 
regulates epidermal development and skeletal morphogenesis in an NF-κB  
independent manner. Keratinocyte-specific Chuk knockout mice, however, exhibit a 
differentiated epidermis with normal epidermal layers, suggesting that the ability of 
Chuk to induce epidermal differentiation is not keratinocyte-autonomous. Despite a 
normally stratified epidermis, the keratinocyte-specific Chuk knockout mice have 
defects in stratum corneum lipid composition and in epidermal tight junctions, 
which leads to impaired epidermal-barrier function and increased transepidermal 
water loss. These defects are caused by the deregulation of retinoic acid target genes 
that encode key lipid modifying enzymes and tight junction proteins in 
keratinocytes. (Gareus et al. 2007) 
 
Ohazama and colleagues determined that Chuk is expressed in the murine tooth 
epithelium and has an essential role in incisor and molar tooth development. Molar 
teeth in Chuk deficient mice, as well as in mice expressing a super-repressor of the 
NF-κB pathway, had abnormal cusp morphology, indicating that Chuk is involved in 
cusp formation through the NF-κB pathway. Incisors, however, had an earlier-onset 
and more severe phenotype, where tooth buds evaginated into the developing oral 
cavity instead of invaginating into the underlying mesenchyme, as supposed to. A 
similar evagination of epithelium was also observed in whisker follicles of Chuk 
mutant animals. Unlike cusp morphogenesis, the NF-κB pathway was not involved 
in the invagination of incisor tooth epithelium. (Ohazama et al. 2004) 
 
NF-κB signalling is also involved in other ectodermal disorders. Mutations in the 
EDA, EDAR, and EDARADD genes that encode activators of the NF-κB pathway, 
cause hypohidrotic ectodermal dysplasia in humans and mice (Kere et al. 1996, 
Ferguson et al. 1997, Srivastava et al. 1997, Headon and Overbeek 1999, Monreal et 
al. 1999, Headon et al. 2001). This disorder causes defects in the development of 
cutaneous structures and is characterized by sparse hair, a lack of sweat glands and 
malformation of teeth. Although these proteins that are crucial for normal hair 
follicle development directly regulate NF-κB signalling, primitive hair follicles were 
still seen in our fetuses lacking CHUK, suggesting that even in the absence of 
CHUK, there is sufficient NF-κB signalling for hair follicles to be formed. 
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5.3.10 CHUK, keratinocyte differentiation and skin cancer 
Chuk deficiency results in the hyperproliferation of keratinocytes, which can be seen 
in the abnormal epidermal structure of Chuk -/- mice that completely lack the 
granular and cornified layers of the epidermis (Hu et al. 1999, Li et al. 1999, Takeda 
et al. 1999). Cultured Chuk -/- keratinocytes do not express the terminal 
differentiation marker filaggrin, and they continue to proliferate even when 
subjected to differentiation-inducing stimuli (Hu et al. 2001). 
 
Squamous cell carcinoma (SCC), a cancer derived from squamous epithelia of the 
skin, head and neck tissues, is the second most common skin cancer in Caucasians 
(Johnson et al. 1992). Mutations in exon 15 of CHUK, which resulted in reduced 
CHUK expression, were described in a few high-grade and poorly differentiated 
human SCCs of the skin (Liu et al. 2006). Epigenetic silencing of the CHUK locus is 
seen in close to 30% of invasive oral SCCs (Maeda et al. 2007). In mice, suprabasal 
overexpression of CHUK results in increased epidermal differentiation and reduced 
keratinocyte proliferation, and inhibits chemically induced SCC formation and 
progression (Liu et al. 2006). Chuk +/- mice developed two times more papillomas 
and 11 times more carcinomas than Chuk +/+ mice, and loss of the wild type Chuk 
allele was seen in some papillomas and most carcinomas (Park et al. 2007). Thus it 
can be concluded that CHUK acts a tumor suppressor in the epidermis by 
controlling keratinocyte proliferation. (Descargues et al. 2008)  However, the role of 
Chuk in cancer seems to be more complex, since studies in mice with mutations in 
Chuk and Ikkβ suggest that (wild type) Chuk promotes metastasis, and Ikkβ 
promotes tumorigenesis (Karin 2008). 
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5.3.11 Cocoon syndrome 
In 1987, Stevenson and colleagues described a “cocoon fetus” born to 
consanguineous parents of Palestinian descent. The male fetus was born at 27 weeks 
gestation, and his extremities were folded and fused to the trunk, although they 
appeared to be of normal lenght. In addition, the fetus had microcephaly, absent 
pinnae, protruding eyes, a protruding tongue, and the mandible was absent. The nose 
was a sharp, beak-like structure. Histological examination of skin showed a thinned 
dermis with no sweat glands or hair follicles, and a thinned epidermis with 
hyperkeratosis. The brain was poorly developed with widely separated cerebral 
hemispheres that lacked the usual morphological landmarks. (Stevenson et al. 1987) 
 
We decided to name our novel fetal encasement malformation Cocoon syndrome 
because of the cocoon-like appearance of the fetuses, and according to the ”cocoon 
fetus” reported by Stevenson and colleagues. The craniofacial malformations seen in 
Stevenson’s case are different from the defects seen in our fetuses, and the structure 
of the skin is also different, since our cases had hair follicles. Also, contrary to the 
hyperkeratosis of the stratum corneum observed in Stevenson’s case, the deficiency 
of Chuk results in the absence of the stratum corneum and hyperproliferation of 
basal keratinocytes. 
 
Following the publication of Original publication II, Cocoon syndrome was assigned 
with a MIM number (MIM 613630). 
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6 Conclusions and future 
 prospects 
This study identified the causative mutations underlying fetal motoneuron diseases 
LCCS1 (MIM 253310) and LAAHD (MIM 611890). In addition, we described a 
novel clinical entity, the Cocoon syndrome (MIM 613630), and its causative 
mutation. Based on the results of this study, DNA based diagnostics of these 
diseases is now possible, and in the case of LCCS1 and LAAHD, already in practice 
at the Helsinki University Hospital Laboratory (HUSLAB). 
 
The study provided significant new information about the molecular mechanisms 
underlying fetal motor neuron disease by showing that GLE1, a gene encoding a 
multifunctional protein involved in posttranscriptional mRNA processing, is 
mutated in LCCS1 and LAAHD. This observation, along with genetic discoveries in 
other motor neuron diseases such as ALS and SMA, highlight the significance of 
mRNA processing in motor neuron disease. Studies on mutant gle1-/- zebrafish 
provided encouraging evidence that LCCS1 pathogenesis could be studied in a 
zebrafish model and laid ground for further experiments. The molecular pathway 
connecting the LCCS1, LCCS2, and LCCS3 disease genes would be an interesting 
line of research. Transgenic mouse models defective in these genes could be 
employed to further evaluate and compare the cellular and developmental 
consequences of the loss of these molecules, as well as their relationship and 
interactions with one another. Studies on Cocoon syndrome suggest that the 
conserved helix-loop-helix ubiquitous kinase CHUK influences both human and 
murine development in a similar manner. However, the craniofacial abnormalities in 
human fetuses lacking CHUK are more severe than defects seen in the Chuk-/- mice, 
suggesting an important role for CHUK in human craniofacial morphogenesis. 
 
During the course of this study, the field of human genetics has come a long way. 
The completion of the Human Genome Project, the current advances in sequencing 
technologies, as well as the increasing availability of web-based resources have 
shifted the focus of human genetic studies from in vitro to in silico. The challenge is 
no longer in producing sequence data, but in analyzing this vast amount of 
information, and understanding the molecular and cellular events that lead to 
disease. The data collected from studies on model organisms has been extremely 
valuable to this study. The use of animal and cell models is also vital in further 
studies of the molecular mechanisms behind human disease. 
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